<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Bull World Health Organ</journal-id><journal-id journal-id-type="iso-abbrev">Bull. World Health Organ</journal-id><journal-id journal-id-type="publisher-id">BLT</journal-id><journal-title-group><journal-title>Bulletin of the World Health Organization</journal-title></journal-title-group><issn pub-type="ppub">0042-9686</issn><issn pub-type="epub">1564-0604</issn><publisher><publisher-name>World Health Organization</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26229204</article-id><article-id pub-id-type="pmc">4431512</article-id><article-id pub-id-type="publisher-id">BLT.14.142141</article-id><article-id pub-id-type="doi">10.2471/BLT.14.142141</article-id><article-categories><subj-group subj-group-type="heading"><subject>Systematic Reviews</subject></subj-group></article-categories><title-group><article-title>Estimates of alcohol-related oesophageal cancer burden in Japan: systematic review and meta-analyses</article-title><trans-title-group xml:lang="fr"><trans-title xml:lang="fr">Estimation de la charge du cancer de l'&#x00153;sophage li&#x000e9; &#x000e0; l'alcool au Japon: revue syst&#x000e9;matique et m&#x000e9;ta-analyses</trans-title></trans-title-group><trans-title-group xml:lang="es"><trans-title xml:lang="es">Estimaciones de la carga del c&#x000e1;ncer esof&#x000e1;gico relacionado con el consumo de alcohol en Jap&#x000f3;n: una revisi&#x000f3;n sistem&#x000e1;tica y metaan&#x000e1;lisis</trans-title></trans-title-group><trans-title-group xml:lang="ar"><trans-title xml:lang="ar">&#x0062a;&#x00642;&#x0062f;&#x0064a;&#x00631;&#x00627;&#x0062a; &#x00639;&#x00628;&#x00621; &#x00633;&#x00631;&#x00637;&#x00627;&#x00646; &#x00627;&#x00644;&#x00645;&#x00631;&#x0064a;&#x00621; &#x00630;&#x0064a; &#x00627;&#x00644;&#x00635;&#x00644;&#x00629; &#x00628;&#x0062a;&#x00639;&#x00627;&#x00637;&#x0064a; &#x00627;&#x00644;&#x00643;&#x0062d;&#x00648;&#x00644; &#x00641;&#x0064a; &#x00627;&#x00644;&#x0064a;&#x00627;&#x00628;&#x00627;&#x00646;: &#x00627;&#x00633;&#x0062a;&#x00639;&#x00631;&#x00627;&#x00636; &#x00645;&#x00646;&#x00647;&#x0062c;&#x0064a; &#x00648;&#x0062a;&#x0062d;&#x00644;&#x0064a;&#x00644;&#x00627;&#x0062a; &#x00648;&#x00635;&#x00641;&#x0064a;&#x00629; </trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title xml:lang="zh">&#x065e5;&#x0672c;&#x09152;&#x07cbe;&#x06027;&#x098df;&#x09053;&#x0764c;&#x08d1f;&#x062c5;&#x07684;&#x04f30;&#x07b97;&#x0ff1a;&#x07cfb;&#x07edf;&#x056de;&#x0987e;&#x04e0e;&#x07efc;&#x05408;&#x05206;&#x06790;</trans-title></trans-title-group><trans-title-group xml:lang="ru"><trans-title xml:lang="ru">&#x0041e;&#x00446;&#x00435;&#x0043d;&#x0043a;&#x00430; &#x00431;&#x00440;&#x00435;&#x0043c;&#x00435;&#x0043d;&#x00438; &#x00440;&#x00430;&#x0043a;&#x00430; &#x0043f;&#x00438;&#x00449;&#x00435;&#x00432;&#x0043e;&#x00434;&#x00430;, &#x0043e;&#x00431;&#x00443;&#x00441;&#x0043b;&#x0043e;&#x00432;&#x0043b;&#x00435;&#x0043d;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x00443;&#x0043f;&#x0043e;&#x00442;&#x00440;&#x00435;&#x00431;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x00435;&#x0043c; &#x00430;&#x0043b;&#x0043a;&#x0043e;&#x00433;&#x0043e;&#x0043b;&#x0044f;, &#x00432; &#x0042f;&#x0043f;&#x0043e;&#x0043d;&#x00438;&#x00438;: &#x00441;&#x00438;&#x00441;&#x00442;&#x00435;&#x0043c;&#x00430;&#x00442;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x00438;&#x00439; &#x0043e;&#x00431;&#x00437;&#x0043e;&#x00440; &#x00438; &#x0043c;&#x00435;&#x00442;&#x00430;&#x00430;&#x0043d;&#x00430;&#x0043b;&#x00438;&#x00437;</trans-title></trans-title-group><alt-title alt-title-type="author-running-head">Michael Roerecke et al.</alt-title><alt-title alt-title-type="title-running-head">Alcohol-related oesophageal cancer in Japan</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Roerecke</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Shield</surname><given-names>Kevin D</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Higuchi</surname><given-names>Susumu</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yoshimura</surname><given-names>Atsushi</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Larsen</surname><given-names>Elisabeth</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rehm</surname><given-names>Maximilien X</given-names></name><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rehm</surname><given-names>J&#x000fc;rgen</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><aff id="aff1"><label>a</label>Centre for Addiction and Mental Health (CAMH), Social and Epidemiological Research Department, Room T523, 33 Russell Street, Toronto, Ontario, M5S 2S1, <country>Canada</country>.</aff><aff id="aff2"><label>b</label>National Hospital Organization, Kurihama Medical and Addiction Center, Yokosuka, <country>Japan</country>.</aff><aff id="aff3"><label>c</label>Ryerson University, Toronto, <country>Canada</country>.</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to Michael Roerecke (email: <email xlink:href="m.roerecke@web.de">m.roerecke@web.de</email>).</corresp></author-notes><pub-date pub-type="ppub"><day>01</day><month>5</month><year>2015</year></pub-date><pub-date pub-type="epub"><day>24</day><month>2</month><year>2015</year></pub-date><volume>93</volume><issue>5</issue><fpage>329</fpage><lpage>338C</lpage><history><date date-type="received"><day>29</day><month>5</month><year>2014</year></date><date date-type="rev-recd"><day>30</day><month>12</month><year>2014</year></date><date date-type="accepted"><day>04</day><month>1</month><year>2015</year></date></history><permissions><copyright-statement>(c) 2015 The authors; licensee World Health Organization.</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/igo/legalcode">http://creativecommons.org/licenses/by/3.0/igo/legalcode</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.</license-p></license></permissions><abstract><title>Abstract</title><sec><title>Objective</title><p>To refine estimates of the burden of alcohol-related oesophageal cancer in Japan.</p></sec><sec><title>Methods</title><p>We searched PubMed for published reviews and original studies on alcohol intake, aldehyde dehydrogenase polymorphisms, and risk for oesophageal cancer in Japan, published before 2014. We conducted random-effects meta-analyses, including subgroup analyses by aldehyde dehydrogenase variants. We estimated deaths and loss of disability-adjusted life years (DALYs) from oesophageal cancer using exposure distributions for alcohol based on age, sex and relative risks per unit of exposure.</p></sec><sec><title>Findings</title><p>We identified 14 relevant studies. Three cohort studies and four case-control studies had dose&#x02013;response data. Evidence from cohort studies showed that people who consumed the equivalent of 100 g/day of pure alcohol had an 11.71 fold, (95% confidence interval, CI: 2.67&#x02013;51.32) risk of oesophageal cancer compared to those who never consumed alcohol. Evidence from case-control studies showed that the increase in risk was 33.11 fold (95% CI: 8.15&#x02013;134.43) in the population at large. The difference by study design is explained by the 159 fold (95% CI: 27.2&#x02013;938.2) risk among those with an inactive aldehyde dehydrogenase enzyme variant. Applying these dose&#x02013;response estimates to the national profile of alcohol intake yielded 5279 oesophageal cancer deaths and 102&#x02009;988 DALYs lost &#x02013; almost double the estimates produced by the most recent global burden of disease exercise.</p></sec><sec><title>Conclusion</title><p>Use of global dose&#x02013;response data results in an underestimate of the burden of disease from oesophageal cancer in Japan. Where possible, national burden of disease studies should use results from the population concerned.</p></sec></abstract><trans-abstract xml:lang="fr"><title>R&#x000e9;sum&#x000e9;</title><sec><title>Objectif</title><p>Affiner les estimations de la charge du cancer de l'&#x00153;sophage li&#x000e9; &#x000e0; l'alcool au Japon.</p></sec><sec><title>M&#x000e9;thodes</title><p>Nous avons effectu&#x000e9; une recherche bibliographique dans PubMed pour trouver les revues publi&#x000e9;es et les &#x000e9;tudes originales sur la consommation d'alcool, les polymorphismes de l'ald&#x000e9;hyde d&#x000e9;shydrog&#x000e9;nase et le risque de d&#x000e9;veloppement d'un cancer de l'&#x00153;sophage au Japon, publi&#x000e9;es avant&#x000a0;2014. Nous avons r&#x000e9;alis&#x000e9; des m&#x000e9;ta-analyses &#x000e0; effet al&#x000e9;atoire, y compris des analyses de sous-groupe par variant de l'ald&#x000e9;hyde d&#x000e9;shydrog&#x000e9;nase. Nous avons estim&#x000e9; les d&#x000e9;c&#x000e8;s et l'esp&#x000e9;rance de vie corrig&#x000e9;e de l'incapacit&#x000e9; (EVCI) dus au cancer de l'&#x00153;sophage en utilisant les distributions de l'exposition &#x000e0; l'alcool en fonction de l'&#x000e2;ge, du sexe et des risques relatifs par unit&#x000e9; d'exposition.</p></sec><sec><title>R&#x000e9;sultats</title><p>Nous avons identifi&#x000e9; 14&#x000a0;&#x000e9;tudes pertinentes. Trois &#x000e9;tudes de cohortes et quatre &#x000e9;tudes de cas-t&#x000e9;moins pr&#x000e9;sentaient des donn&#x000e9;es de dose-r&#x000e9;ponse. Les donn&#x000e9;es issues des &#x000e9;tudes de cohortes montrent que les personnes ayant consomm&#x000e9; l'&#x000e9;quivalent de 100&#x000a0;g/jour d'alcool pur avaient un risque 11,71&#x000a0;fois sup&#x000e9;rieur (intervalle de confiance &#x000e0; 95% [IC]: 2,67&#x02013;51,32) de d&#x000e9;velopper un cancer de l'&#x00153;sophage par rapport aux personnes qui n'ont jamais consomm&#x000e9; d'alcool. Les donn&#x000e9;es obtenues &#x000e0; partir des &#x000e9;tudes de cas-t&#x000e9;moins ont montr&#x000e9; que l'augmentation du risque &#x000e9;tait 33,11&#x000a0;fois sup&#x000e9;rieure (IC &#x000e0; 95%: 8,15&#x02013;134,43) par rapport &#x000e0; la population en g&#x000e9;n&#x000e9;ral. La diff&#x000e9;rence par la conception de l'&#x000e9;tude est expliqu&#x000e9;e par un risque 159&#x000a0;fois sup&#x000e9;rieur (IC &#x000e0; 95%: 27,2&#x02013;938,2) parmi les personnes pr&#x000e9;sentant un variant enzymatique inactif de l'ald&#x000e9;hyde d&#x000e9;shydrog&#x000e9;nase. En appliquant ces estimations de dose-r&#x000e9;ponse au profil national de consommation d'alcool, nous sommes arriv&#x000e9;s &#x000e0; 5279&#x000a0;d&#x000e9;c&#x000e8;s et 102&#x000a0;988&#x000a0;EVCI dus au cancer de l'&#x00153;sophage &#x02013; soit presque le double des estimations produites par la plus r&#x000e9;cente charge globale de la maladie.</p></sec><sec><title>Conclusion</title><p>L'utilisation de donn&#x000e9;es globales de dose-r&#x000e9;ponse se traduit par une sous-estimation de la charge de morbidit&#x000e9; pour le cancer de l'&#x00153;sophage au Japon. Dans la mesure du possible, la charge nationale des &#x000e9;tudes portant sur les maladies devrait utiliser les r&#x000e9;sultats obtenus sur la population concern&#x000e9;e.</p></sec></trans-abstract><trans-abstract xml:lang="es"><title>Resumen</title><sec><title>Objetivo</title><p>Refinar las estimaciones de la carga del c&#x000e1;ncer esof&#x000e1;gico relacionado con el consumo de alcohol en Jap&#x000f3;n.</p></sec><sec><title>M&#x000e9;todos</title><p>Se buscaron revisiones y estudios originales publicados antes de 2014 sobre la ingesta de alcohol, polimorfismos del aldeh&#x000ed;do deshidrogenasa y el riesgo de c&#x000e1;ncer de es&#x000f3;fago en Jap&#x000f3;n en la base de datos PubMed. Se efectuaron metaan&#x000e1;lisis de efectos aleatorios, que inclu&#x000ed;an an&#x000e1;lisis de subgrupos de variantes del aldeh&#x000ed;do deshidrogenasa y se estimaron las muertes y la p&#x000e9;rdida de a&#x000f1;os de vida ajustados por discapacidad (AVAD) por c&#x000e1;ncer de es&#x000f3;fago mediante distribuciones de exposici&#x000f3;n para el alcohol basadas en la edad, el sexo y los riesgos relativos por unidad de exposici&#x000f3;n.</p></sec><sec><title>Resultados</title><p>Se identificaron 14 estudios pertinentes. Tres estudios de cohorte y cuatro estudios de casos y controles conten&#x000ed;an datos sobre la respuesta en relaci&#x000f3;n con la dosis. Las pruebas de los estudios de cohorte demostraron que el riesgo de c&#x000e1;ncer esof&#x000e1;gico de que quienes consumen el equivalente a 100 g/d&#x000ed;a de alcohol puro era 11,71 veces mayor (intervalo de confianza del 95 % [IC]: 2,67&#x02013;51,32) en comparaci&#x000f3;n con aquellos que nunca consumieron alcohol. Las pruebas de los estudios de casos y controles demostraron que el riesgo aument&#x000f3; 33,11 veces (IC del 95 %: 8,15&#x02013;134,43) en la poblaci&#x000f3;n en general. La diferencia por el dise&#x000f1;o del estudio se explica por el aumento en 159 veces (IC del 95 %: 27,2&#x02013;938,2) del riesgo entre las personas con una variante inactiva de la enzima aldeh&#x000ed;do deshidrogenasa. La aplicaci&#x000f3;n de estas estimaciones de la respuesta en relaci&#x000f3;n con la dosis al perfil nacional del consumo de alcohol dio lugar a la notificaci&#x000f3;n de 5279 muertes de c&#x000e1;ncer esof&#x000e1;gico y 102 988 AVAD perdidos, lo equivale a casi el doble de las estimaciones producidas por la carga mundial m&#x000e1;s reciente de la actividad de la enfermedad.</p></sec><sec><title>Conclusi&#x000f3;n</title><p>El uso de datos mundiales sobre la respuesta en relaci&#x000f3;n con la dosis da lugar a una subestimaci&#x000f3;n de la carga de enfermedad de c&#x000e1;ncer esof&#x000e1;gico en Jap&#x000f3;n. Siempre que sea posible, los estudios sobre la carga nacional de la enfermedad deben utilizar los resultados de la poblaci&#x000f3;n afectada.</p></sec></trans-abstract><trans-abstract xml:lang="ar"><title>&#x00645;&#x00644;&#x0062e;&#x00635; </title><sec><title>&#x00627;&#x00644;&#x0063a;&#x00631;&#x00636; </title><p>&#x0062a;&#x00646;&#x00642;&#x0064a;&#x0062d; &#x0062a;&#x00642;&#x0062f;&#x0064a;&#x00631;&#x00627;&#x0062a; &#x00639;&#x00628;&#x00621; &#x00633;&#x00631;&#x00637;&#x00627;&#x00646; &#x00627;&#x00644;&#x00645;&#x00631;&#x0064a;&#x00621; &#x00630;&#x0064a; &#x00627;&#x00644;&#x00635;&#x00644;&#x00629; &#x00628;&#x0062a;&#x00639;&#x00627;&#x00637;&#x0064a; &#x00627;&#x00644;&#x00643;&#x0062d;&#x00648;&#x00644; &#x00641;&#x0064a; &#x00627;&#x00644;&#x0064a;&#x00627;&#x00628;&#x00627;&#x00646;. </p></sec><sec><title>&#x00627;&#x00644;&#x00637;&#x00631;&#x0064a;&#x00642;&#x00629; </title><p>&#x00623;&#x0062c;&#x00631;&#x0064a;&#x00646;&#x00627; &#x00628;&#x0062d;&#x0062b;&#x00627;&#x0064b; &#x00641;&#x0064a; &#x00642;&#x00627;&#x00639;&#x0062f;&#x00629; &#x00628;&#x0064a;&#x00627;&#x00646;&#x00627;&#x0062a; PubMed &#x00639;&#x00646; &#x00627;&#x00644;&#x00627;&#x00633;&#x0062a;&#x00639;&#x00631;&#x00627;&#x00636;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x00646;&#x00634;&#x00648;&#x00631;&#x00629; &#x00648;&#x00627;&#x00644;&#x0062f;&#x00631;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00623;&#x00635;&#x00644;&#x0064a;&#x00629; &#x0062d;&#x00648;&#x00644; &#x0062a;&#x00639;&#x00627;&#x00637;&#x0064a; &#x00627;&#x00644;&#x00643;&#x0062d;&#x00648;&#x00644; &#x00648;&#x0062a;&#x00639;&#x0062f;&#x0062f; &#x00623;&#x00634;&#x00643;&#x00627;&#x00644; &#x00646;&#x00627;&#x00632;&#x00639;&#x00629; &#x00647;&#x0064a;&#x0062f;&#x00631;&#x00648;&#x0062c;&#x0064a;&#x00646; &#x00627;&#x00644;&#x00623;&#x00644;&#x0062f;&#x00647;&#x0064a;&#x0062f; &#x00648;&#x00627;&#x0062e;&#x0062a;&#x00637;&#x00627;&#x00631; &#x00633;&#x00631;&#x00637;&#x00627;&#x00646; &#x00627;&#x00644;&#x00645;&#x00631;&#x0064a;&#x00621; &#x00641;&#x0064a; &#x00627;&#x00644;&#x0064a;&#x00627;&#x00628;&#x00627;&#x00646;&#x0060c; &#x00627;&#x00644;&#x0062a;&#x0064a; &#x0062a;&#x00645; &#x00646;&#x00634;&#x00631;&#x00647;&#x00627; &#x00642;&#x00628;&#x00644; &#x00639;&#x00627;&#x00645; 2014. &#x00648;&#x00623;&#x0062c;&#x00631;&#x0064a;&#x00646;&#x00627; &#x0062a;&#x0062d;&#x00644;&#x0064a;&#x00644;&#x00627;&#x0062a; &#x00648;&#x00635;&#x00641;&#x0064a;&#x00629; &#x00644;&#x00644;&#x0062a;&#x00623;&#x0062b;&#x0064a;&#x00631;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00639;&#x00634;&#x00648;&#x00627;&#x00626;&#x0064a;&#x00629;&#x0060c; &#x00628;&#x00645;&#x00627; &#x00641;&#x0064a; &#x00630;&#x00644;&#x00643; &#x0062a;&#x0062d;&#x00644;&#x0064a;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00641;&#x00626;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00641;&#x00631;&#x00639;&#x0064a;&#x00629; &#x0062d;&#x00633;&#x00628; &#x00645;&#x0062a;&#x0063a;&#x0064a;&#x00631;&#x00627;&#x0062a; &#x00646;&#x00627;&#x00632;&#x00639;&#x00629; &#x00647;&#x0064a;&#x0062f;&#x00631;&#x00648;&#x0062c;&#x0064a;&#x00646; &#x00627;&#x00644;&#x00623;&#x00644;&#x0062f;&#x00647;&#x0064a;&#x0062f;. &#x00648;&#x00642;&#x00645;&#x00646;&#x00627; &#x00628;&#x0062a;&#x00642;&#x0062f;&#x0064a;&#x00631; &#x0062d;&#x00627;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00648;&#x00641;&#x00627;&#x00629; &#x00648;&#x00641;&#x00642;&#x0062f;&#x00627;&#x00646; &#x00633;&#x00646;&#x00648;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00639;&#x00645;&#x00631; &#x00627;&#x00644;&#x00645;&#x00635;&#x0062d;&#x0062d;&#x00629; &#x00628;&#x00627;&#x0062d;&#x0062a;&#x00633;&#x00627;&#x00628; &#x00645;&#x0062f;&#x0062f; &#x00627;&#x00644;&#x00639;&#x0062c;&#x00632; &#x0062c;&#x00631;&#x00627;&#x00621; &#x00627;&#x00644;&#x00625;&#x00635;&#x00627;&#x00628;&#x00629; &#x00628;&#x00633;&#x00631;&#x00637;&#x00627;&#x00646; &#x00627;&#x00644;&#x00645;&#x00631;&#x0064a;&#x00621; &#x00628;&#x00627;&#x00633;&#x0062a;&#x0062e;&#x0062f;&#x00627;&#x00645; &#x0062a;&#x00648;&#x00632;&#x0064a;&#x00639;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062a;&#x00639;&#x00631;&#x00636; &#x00644;&#x00644;&#x00643;&#x0062d;&#x00648;&#x00644; &#x00627;&#x00633;&#x0062a;&#x00646;&#x00627;&#x0062f;&#x00627;&#x0064b; &#x00625;&#x00644;&#x00649; &#x00627;&#x00644;&#x00633;&#x00646; &#x00648;&#x00627;&#x00644;&#x0062c;&#x00646;&#x00633; &#x00648;&#x00627;&#x00644;&#x00645;&#x0062e;&#x00627;&#x00637;&#x00631; &#x00627;&#x00644;&#x00646;&#x00633;&#x00628;&#x0064a;&#x00629; &#x00644;&#x00643;&#x00644; &#x00648;&#x0062d;&#x0062f;&#x00629; &#x0062a;&#x00639;&#x00631;&#x00636;. </p></sec><sec><title>&#x00627;&#x00644;&#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; </title><p>&#x00642;&#x00645;&#x00646;&#x00627; &#x00628;&#x0062a;&#x0062d;&#x0062f;&#x0064a;&#x0062f; 14 &#x0062f;&#x00631;&#x00627;&#x00633;&#x00629; &#x00630;&#x00627;&#x0062a; &#x00635;&#x00644;&#x00629;. &#x00648;&#x00627;&#x00634;&#x0062a;&#x00645;&#x00644;&#x0062a; &#x0062b;&#x00644;&#x00627;&#x0062b; &#x0062f;&#x00631;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00623;&#x0062a;&#x00631;&#x00627;&#x00628;&#x0064a;&#x00629; &#x00648;&#x00623;&#x00631;&#x00628;&#x00639; &#x0062f;&#x00631;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00644;&#x0062d;&#x00627;&#x00644;&#x00627;&#x0062a; &#x00625;&#x00641;&#x00631;&#x00627;&#x0062f;&#x0064a;&#x00629; &#x00645;&#x00642;&#x0062a;&#x00631;&#x00646;&#x00629; &#x00628;&#x0062d;&#x00627;&#x00644;&#x00627;&#x0062a; &#x00636;&#x00627;&#x00628;&#x00637;&#x00629; &#x00639;&#x00644;&#x00649; &#x00628;&#x0064a;&#x00627;&#x00646;&#x00627;&#x0062a; &#x00639;&#x00646; &#x00639;&#x00644;&#x00627;&#x00642;&#x00629; &#x00627;&#x00644;&#x0062c;&#x00631;&#x00639;&#x00629; &#x00628;&#x00627;&#x00644;&#x00627;&#x00633;&#x0062a;&#x0062c;&#x00627;&#x00628;&#x00629;. &#x00648;&#x00623;&#x00638;&#x00647;&#x00631;&#x0062a; &#x00627;&#x00644;&#x00628;&#x0064a;&#x00651;&#x00646;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00645;&#x0062f;&#x00629; &#x00645;&#x00646; &#x00627;&#x00644;&#x0062f;&#x00631;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00623;&#x0062a;&#x00631;&#x00627;&#x00628;&#x0064a;&#x00629; &#x0062a;&#x00639;&#x00631;&#x00636; &#x00627;&#x00644;&#x00623;&#x00634;&#x0062e;&#x00627;&#x00635; &#x00627;&#x00644;&#x00630;&#x0064a;&#x00646; &#x0062a;&#x00639;&#x00627;&#x00637;&#x00648;&#x00627; &#x00645;&#x00627; &#x0064a;&#x00639;&#x00627;&#x0062f;&#x00644; 100 &#x0063a;&#x00645;/&#x0064a;&#x00648;&#x00645; &#x00645;&#x00646; &#x00627;&#x00644;&#x00643;&#x0062d;&#x00648;&#x00644; &#x00627;&#x00644;&#x00635;&#x00627;&#x00641;&#x0064a; &#x00625;&#x00644;&#x00649; &#x0062e;&#x00637;&#x00648;&#x00631;&#x00629; &#x00627;&#x00644;&#x00625;&#x00635;&#x00627;&#x00628;&#x00629; &#x00628;&#x00633;&#x00631;&#x00637;&#x00627;&#x00646; &#x00627;&#x00644;&#x00645;&#x00631;&#x0064a;&#x00621; &#x00628;&#x00645;&#x00642;&#x0062f;&#x00627;&#x00631; 11.71 &#x00645;&#x00631;&#x00629; (&#x00641;&#x00627;&#x00635;&#x00644; &#x00627;&#x00644;&#x0062b;&#x00642;&#x00629; <styled-content style-type="direction" style="direction:ltr;">95&#x000a0;%</styled-content>&#x0061b; &#x00641;&#x00627;&#x00635;&#x00644; &#x00627;&#x00644;&#x0062b;&#x00642;&#x00629;: &#x00645;&#x00646; 2.67 &#x00625;&#x00644;&#x00649; 51.32) &#x00645;&#x00642;&#x00627;&#x00631;&#x00646;&#x00629; &#x00628;&#x00627;&#x00644;&#x00630;&#x0064a;&#x00646; &#x00644;&#x00645; &#x0064a;&#x0062a;&#x00639;&#x00627;&#x00637;&#x00648;&#x00627; &#x00627;&#x00644;&#x00643;&#x0062d;&#x00648;&#x00644; &#x00625;&#x00637;&#x00644;&#x00627;&#x00642;&#x00627;&#x0064b;. &#x00648;&#x00623;&#x00638;&#x00647;&#x00631;&#x0062a; &#x00627;&#x00644;&#x00628;&#x0064a;&#x00651;&#x00646;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00645;&#x0062f;&#x00629; &#x00645;&#x00646; &#x0062f;&#x00631;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062d;&#x00627;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00625;&#x00641;&#x00631;&#x00627;&#x0062f;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00645;&#x00642;&#x0062a;&#x00631;&#x00646;&#x00629; &#x00628;&#x0062d;&#x00627;&#x00644;&#x00627;&#x0062a; &#x00636;&#x00627;&#x00628;&#x00637;&#x00629; &#x00623;&#x00646; &#x00627;&#x00644;&#x00632;&#x0064a;&#x00627;&#x0062f;&#x00629; &#x00641;&#x0064a; &#x00627;&#x00644;&#x0062e;&#x00637;&#x00648;&#x00631;&#x00629; &#x00628;&#x00644;&#x0063a;&#x0062a; 33.11 &#x00645;&#x00631;&#x00629; (&#x00641;&#x00627;&#x00635;&#x00644; &#x00627;&#x00644;&#x0062b;&#x00642;&#x00629; <styled-content style-type="direction" style="direction:ltr;">95&#x000a0;%</styled-content>&#x0061b; &#x00641;&#x00627;&#x00635;&#x00644; &#x00627;&#x00644;&#x0062b;&#x00642;&#x00629;: &#x00645;&#x00646; 8.15 &#x00625;&#x00644;&#x00649; 134.43) &#x00641;&#x0064a; &#x00639;&#x00627;&#x00645;&#x00629; &#x00627;&#x00644;&#x00633;&#x00643;&#x00627;&#x00646;. &#x00648;&#x0064a;&#x0062a;&#x00636;&#x0062d; &#x00627;&#x00644;&#x00641;&#x00631;&#x00642; &#x0062d;&#x00633;&#x00628; &#x0062a;&#x00635;&#x00645;&#x0064a;&#x00645; &#x00627;&#x00644;&#x0062f;&#x00631;&#x00627;&#x00633;&#x00629; &#x00641;&#x0064a; &#x00627;&#x00644;&#x0062e;&#x00637;&#x00648;&#x00631;&#x00629; &#x00627;&#x00644;&#x0062a;&#x0064a; &#x00628;&#x00644;&#x0063a;&#x0062a; 159 &#x00645;&#x00631;&#x00629; (&#x00641;&#x00627;&#x00635;&#x00644; &#x00627;&#x00644;&#x0062b;&#x00642;&#x00629; <styled-content style-type="direction" style="direction:ltr;">95&#x000a0;%</styled-content>&#x0061b; &#x00641;&#x00627;&#x00635;&#x00644; &#x00627;&#x00644;&#x0062b;&#x00642;&#x00629;: &#x00645;&#x00646; 27.2 &#x00625;&#x00644;&#x00649; 938.2) &#x00628;&#x0064a;&#x00646; &#x00627;&#x00644;&#x00623;&#x00634;&#x0062e;&#x00627;&#x00635; &#x00627;&#x00644;&#x00630;&#x0064a;&#x00646; &#x00644;&#x0062f;&#x0064a;&#x00647;&#x00645; &#x00645;&#x0062a;&#x0063a;&#x0064a;&#x00631; &#x0063a;&#x0064a;&#x00631; &#x00641;&#x00639;&#x00627;&#x00644; &#x00644;&#x00625;&#x00646;&#x00632;&#x0064a;&#x00645; &#x00646;&#x00627;&#x00632;&#x00639;&#x00629; &#x00647;&#x0064a;&#x0062f;&#x00631;&#x00648;&#x0062c;&#x0064a;&#x00646; &#x00627;&#x00644;&#x00623;&#x00644;&#x0062f;&#x00647;&#x0064a;&#x0062f;. &#x00648;&#x00646;&#x0062a;&#x0062c; &#x00639;&#x00646; &#x0062a;&#x00637;&#x00628;&#x0064a;&#x00642; &#x00647;&#x00630;&#x00647; &#x00627;&#x00644;&#x0062a;&#x00642;&#x0062f;&#x0064a;&#x00631;&#x00627;&#x0062a; &#x00644;&#x00639;&#x00644;&#x00627;&#x00642;&#x00629; &#x00627;&#x00644;&#x0062c;&#x00631;&#x00639;&#x00629; &#x00628;&#x00627;&#x00644;&#x00627;&#x00633;&#x0062a;&#x0062c;&#x00627;&#x00628;&#x00629; &#x00639;&#x00644;&#x00649; &#x00627;&#x00644;&#x00645;&#x00631;&#x0062a;&#x00633;&#x00645; &#x00627;&#x00644;&#x00648;&#x00637;&#x00646;&#x0064a; &#x00644;&#x0062a;&#x00639;&#x00627;&#x00637;&#x0064a; &#x00627;&#x00644;&#x00643;&#x0062d;&#x00648;&#x00644; 5279 &#x0062d;&#x00627;&#x00644;&#x00629; &#x00648;&#x00641;&#x00627;&#x00629; &#x00628;&#x00633;&#x00631;&#x00637;&#x00627;&#x00646; &#x00627;&#x00644;&#x00645;&#x00631;&#x0064a;&#x00621; &#x00648;&#x00641;&#x00642;&#x0062f;&#x00627;&#x00646; 102988 &#x00645;&#x00646; &#x00633;&#x00646;&#x00648;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00639;&#x00645;&#x00631; &#x00627;&#x00644;&#x00645;&#x00635;&#x0062d;&#x0062d;&#x00629; &#x00628;&#x00627;&#x0062d;&#x0062a;&#x00633;&#x00627;&#x00628; &#x00645;&#x0062f;&#x0062f; &#x00627;&#x00644;&#x00639;&#x0062c;&#x00632; <styled-content style-type="direction" style="direction:ltr;">- </styled-content>&#x00648;&#x00647;&#x00648; &#x0062a;&#x00642;&#x00631;&#x0064a;&#x00628;&#x00627;&#x0064b; &#x00636;&#x00639;&#x00641; &#x00627;&#x00644;&#x0062a;&#x00642;&#x0062f;&#x0064a;&#x00631;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00646;&#x00627;&#x0062a;&#x0062c;&#x00629; &#x00639;&#x00646; &#x00627;&#x00644;&#x00639;&#x00628;&#x00621; &#x00627;&#x00644;&#x00639;&#x00627;&#x00644;&#x00645;&#x0064a; &#x00627;&#x00644;&#x00623;&#x0062d;&#x0062f;&#x0062b; &#x00644;&#x00645;&#x00645;&#x00627;&#x00631;&#x00633;&#x00629; &#x00627;&#x00644;&#x00645;&#x00631;&#x00636;. </p></sec><sec><title>&#x00627;&#x00644;&#x00627;&#x00633;&#x0062a;&#x00646;&#x0062a;&#x00627;&#x0062c; </title><p>&#x0064a;&#x00646;&#x0062a;&#x0062c; &#x00639;&#x00646; &#x00627;&#x00633;&#x0062a;&#x0062e;&#x0062f;&#x00627;&#x00645; &#x00628;&#x0064a;&#x00627;&#x00646;&#x00627;&#x0062a; &#x00639;&#x00644;&#x00627;&#x00642;&#x00629; &#x00627;&#x00644;&#x0062c;&#x00631;&#x00639;&#x00629; &#x00628;&#x00627;&#x00644;&#x00627;&#x00633;&#x0062a;&#x0062c;&#x00627;&#x00628;&#x00629; &#x00639;&#x00644;&#x00649; &#x00627;&#x00644;&#x00635;&#x00639;&#x0064a;&#x0062f; &#x00627;&#x00644;&#x00639;&#x00627;&#x00644;&#x00645;&#x0064a; &#x00627;&#x00644;&#x0062a;&#x00642;&#x00644;&#x0064a;&#x00644; &#x00645;&#x00646; &#x0062a;&#x00642;&#x0062f;&#x0064a;&#x00631; &#x00639;&#x00628;&#x00621; &#x00627;&#x00644;&#x00645;&#x00631;&#x00636; &#x00627;&#x00644;&#x00646;&#x00627;&#x0062c;&#x00645; &#x00639;&#x00646; &#x00633;&#x00631;&#x00637;&#x00627;&#x00646; &#x00627;&#x00644;&#x00645;&#x00631;&#x0064a;&#x00621; &#x00641;&#x0064a; &#x00627;&#x00644;&#x0064a;&#x00627;&#x00628;&#x00627;&#x00646;. &#x00648;&#x0064a;&#x00646;&#x00628;&#x0063a;&#x0064a; &#x00623;&#x00646; &#x0062a;&#x00633;&#x0062a;&#x0062e;&#x0062f;&#x00645; &#x0062f;&#x00631;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00639;&#x00628;&#x00621; &#x00627;&#x00644;&#x00645;&#x00631;&#x00636; &#x00639;&#x00644;&#x00649; &#x00627;&#x00644;&#x00635;&#x00639;&#x0064a;&#x0062f; &#x00627;&#x00644;&#x00648;&#x00637;&#x00646;&#x0064a; &#x00627;&#x00644;&#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; &#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00645;&#x0062f;&#x00629; &#x00645;&#x00646; &#x00627;&#x00644;&#x00633;&#x00643;&#x00627;&#x00646; &#x00627;&#x00644;&#x00645;&#x00639;&#x00646;&#x0064a;&#x0064a;&#x00646; &#x0062d;&#x00633;&#x00628;&#x00645;&#x00627; &#x00623;&#x00645;&#x00643;&#x00646;. </p></sec></trans-abstract><trans-abstract xml:lang="zh"><title>&#x06458;&#x08981;</title><sec><title>&#x076ee;&#x07684;</title><p>&#x05f97;&#x05230;&#x066f4;&#x07cbe;&#x0786e;&#x07684;&#x065e5;&#x0672c;&#x09152;&#x07cbe;&#x06027;&#x098df;&#x09053;&#x0764c;&#x08d1f;&#x062c5;&#x04f30;&#x07b97;&#x0503c;&#x03002;</p></sec><sec><title>&#x065b9;&#x06cd5;</title><p>&#x06211;&#x04eec;&#x0641c;&#x07d22;PubMed&#x06570;&#x0636e;&#x05e93;&#x0ff0c;&#x067e5;&#x0627e;2014&#x05e74;&#x0524d;&#x053d1;&#x08868;&#x07684;&#x05173;&#x04e8e;&#x065e5;&#x0672c;&#x09152;&#x07cbe;&#x06444;&#x05165;&#x03001;&#x04e59;&#x0919b;&#x08131;&#x06c22;&#x09176;&#x0591a;&#x06001;&#x06027;&#x04ee5;&#x053ca;&#x098df;&#x09053;&#x0764c;&#x098ce;&#x09669;&#x07684;&#x07efc;&#x08ff0;&#x04e0e;&#x0539f;&#x059cb;&#x07814;&#x07a76;&#x03002;&#x06211;&#x04eec;&#x08fd8;&#x08fdb;&#x0884c;&#x04e86;&#x0968f;&#x0673a;&#x05f71;&#x054cd;&#x07efc;&#x05408;&#x05206;&#x06790;&#x0ff0c;&#x05305;&#x062ec;&#x07528;&#x04e59;&#x0919b;&#x08131;&#x06c27;&#x09176;&#x053d8;&#x04f53;&#x08fdb;&#x0884c;&#x07684;&#x04e9a;&#x07ec4;&#x05206;&#x06790;&#x03002;&#x06839;&#x0636e;&#x09152;&#x07cbe;&#x05f71;&#x054cd;&#x07c7b;&#x0522b;&#x07684;&#x05e74;&#x09f84;&#x03001;&#x06027;&#x0522b;&#x053ca;&#x076f8;&#x05bf9;&#x098ce;&#x09669;&#x0ff0c;&#x06211;&#x04eec;&#x04f7f;&#x07528;&#x09152;&#x07cbe;&#x05f71;&#x054cd;&#x05206;&#x05e03;&#x04f30;&#x07b97;&#x04e86;&#x098df;&#x09053;&#x0764c;&#x06b7b;&#x04ea1;&#x07387;&#x04e0e;&#x06b8b;&#x075be;&#x08c03;&#x06574;&#x0751f;&#x0547d;&#x05e74;&#x0ff08;DALY&#x0ff09;&#x07684;&#x0635f;&#x05931;&#x03002;</p></sec><sec><title>&#x07ed3;&#x0679c;</title><p>&#x06211;&#x04eec;&#x0627e;&#x05230;&#x04e86;14&#x09879;&#x076f8;&#x05173;&#x07814;&#x07a76;&#x03002;&#x04e09;&#x09879;&#x0961f;&#x05217;&#x07814;&#x07a76;&#x0548c;&#x056db;&#x09879;&#x075c5;&#x04f8b;&#x05bf9;&#x07167;&#x07814;&#x07a76;&#x063d0;&#x04f9b;&#x05242;&#x091cf;&#x053cd;&#x05e94;&#x07684;&#x06570;&#x0636e;&#x03002;&#x0961f;&#x05217;&#x07814;&#x07a76;&#x07684;&#x08bc1;&#x0636e;&#x08868;&#x0660e;&#x0ff0c;&#x04e0e;&#x04ece;&#x04e0d;&#x0996e;&#x09152;&#x07684;&#x04eba;&#x07fa4;&#x076f8;&#x06bd4;&#x08f83;&#x0ff0c;&#x08fd9;&#x04e9b;&#x06bcf;&#x05929;&#x06d88;&#x08017;&#x076f8;&#x05f53;&#x04e8e;100&#x0514b;&#x07eaf;&#x09152;&#x07cbe;&#x07684;&#x04eba;&#x07fa4;&#x060a3;&#x098df;&#x09053;&#x0764c;&#x07684;&#x098ce;&#x09669;&#x0662f;&#x0524d;&#x08005;&#x07684;11.71&#x0500d;&#x0ff08;95%&#x07f6e;&#x04fe1;&#x0533a;&#x095f4;&#x0ff0c;CI&#x0ff1a;2.67-51.32&#x0ff09;&#x03002;&#x075c5;&#x04f8b;&#x05bf9;&#x07167;&#x07814;&#x07a76;&#x07684;&#x08bc1;&#x0636e;&#x08868;&#x0660e;&#x0ff0c;&#x04ece;&#x06574;&#x04f53;&#x04eba;&#x053e3;&#x065b9;&#x09762;&#x0770b;&#x0ff0c;&#x060a3;&#x098df;&#x09053;&#x0764c;&#x07684;&#x098ce;&#x09669;&#x0589e;&#x052a0;&#x04e86;33.11&#x0500d;&#x0ff08;95%&#x07f6e;&#x04fe1;&#x0533a;&#x095f4;&#x0ff0c;CI&#x0ff1a;8.15-134.43&#x0ff09;&#x03002;&#x07814;&#x07a76;&#x08bbe;&#x08ba1;&#x053d1;&#x073b0;&#x07684;&#x05dee;&#x05f02;&#x0663e;&#x0793a;&#x0ff0c;&#x0643a;&#x05e26;&#x04e0d;&#x06d3b;&#x08dc3;&#x04e59;&#x0919b;&#x08131;&#x06c22;&#x09176;&#x053d8;&#x04f53;&#x07684;&#x04eba;&#x060a3;&#x098df;&#x09053;&#x0764c;&#x07684;&#x098ce;&#x09669;&#x0662f;159&#x0500d;&#x0ff08;95%&#x0ff0c;CI&#x0ff1a;27.2-938.2&#x0ff09;&#x03002;&#x0628a;&#x08fd9;&#x04e9b;&#x05242;&#x091cf;&#x053cd;&#x05e94;&#x06570;&#x0503c;&#x05e94;&#x07528;&#x05230;&#x05168;&#x056fd;&#x09152;&#x07cbe;&#x06444;&#x05165;&#x06570;&#x0636e;&#x04e2d;&#x0ff0c;&#x06211;&#x04eec;&#x05f97;&#x051fa;&#x098df;&#x09053;&#x0764c;&#x06b7b;&#x04ea1;&#x04eba;&#x06570;&#x0662f;5279&#x04eba;&#x0ff0c;&#x06b8b;&#x075be;&#x08c03;&#x06574;&#x0751f;&#x0547d;&#x05e74;&#x0635f;&#x05931;&#x0662f;102988&#x05e74;&#x0ff0c;&#x08fd9;&#x04e9b;&#x06570;&#x0636e;&#x051e0;&#x04e4e;&#x0662f;&#x06700;&#x065b0;&#x05168;&#x07403;&#x075be;&#x075c5;&#x08d1f;&#x062c5;&#x07814;&#x07a76;&#x06570;&#x0636e;&#x07684;&#x04e24;&#x0500d;&#x03002;</p></sec><sec><title>&#x07ed3;&#x08bba;</title><p>&#x04f7f;&#x07528;&#x05168;&#x07403;&#x05242;&#x091cf;&#x053cd;&#x05e94;&#x06570;&#x0636e;&#x05bfc;&#x081f4;&#x05bf9;&#x065e5;&#x0672c;&#x098df;&#x09053;&#x0764c;&#x075be;&#x075c5;&#x08d1f;&#x062c5;&#x07684;&#x04f4e;&#x04f30;&#x03002;&#x05728;&#x053ef;&#x080fd;&#x07684;&#x060c5;&#x051b5;&#x04e0b;&#x0ff0c;&#x05168;&#x056fd;&#x075be;&#x075c5;&#x08d1f;&#x062c5;&#x07814;&#x07a76;&#x05e94;&#x08be5;&#x04f7f;&#x07528;&#x076f8;&#x05173;&#x04eba;&#x07fa4;&#x07684;&#x07814;&#x07a76;&#x07ed3;&#x0679c;&#x03002;</p></sec></trans-abstract><trans-abstract xml:lang="ru"><title>&#x00420;&#x00435;&#x00437;&#x0044e;&#x0043c;&#x00435;</title><sec><title>&#x00426;&#x00435;&#x0043b;&#x0044c;</title><p>&#x00412;&#x0044b;&#x0043f;&#x0043e;&#x0043b;&#x0043d;&#x00438;&#x00442;&#x0044c; &#x00442;&#x0043e;&#x00447;&#x0043d;&#x00443;&#x0044e; &#x0043e;&#x00446;&#x00435;&#x0043d;&#x0043a;&#x00443; &#x00431;&#x00440;&#x00435;&#x0043c;&#x00435;&#x0043d;&#x00438; &#x00440;&#x00430;&#x0043a;&#x00430; &#x0043f;&#x00438;&#x00449;&#x00435;&#x00432;&#x0043e;&#x00434;&#x00430;, &#x0043e;&#x00431;&#x00443;&#x00441;&#x0043b;&#x0043e;&#x00432;&#x0043b;&#x00435;&#x0043d;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x00443;&#x0043f;&#x0043e;&#x00442;&#x00440;&#x00435;&#x00431;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x00435;&#x0043c; &#x00430;&#x0043b;&#x0043a;&#x0043e;&#x00433;&#x0043e;&#x0043b;&#x0044f;, &#x00432; &#x0042f;&#x0043f;&#x0043e;&#x0043d;&#x00438;&#x00438;.</p></sec><sec><title>&#x0041c;&#x00435;&#x00442;&#x0043e;&#x00434;&#x0044b;</title><p>&#x0041c;&#x0044b; &#x00438;&#x00437;&#x00443;&#x00447;&#x00438;&#x0043b;&#x00438; &#x00441;&#x0043e;&#x00434;&#x00435;&#x00440;&#x00436;&#x00430;&#x00449;&#x00443;&#x0044e;&#x00441;&#x0044f; &#x00432; &#x00431;&#x00430;&#x00437;&#x00435; &#x00434;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445; PubMed &#x00438;&#x0043d;&#x00444;&#x0043e;&#x00440;&#x0043c;&#x00430;&#x00446;&#x00438;&#x0044e; &#x0043f;&#x0043e; &#x0043e;&#x0043f;&#x00443;&#x00431;&#x0043b;&#x00438;&#x0043a;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x0043c; &#x00434;&#x0043e; 2014&#x000a0;&#x00433;. &#x0043e;&#x00431;&#x00437;&#x0043e;&#x00440;&#x00430;&#x0043c; &#x00438; &#x0043e;&#x00440;&#x00438;&#x00433;&#x00438;&#x0043d;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x0043c; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f;&#x0043c;, &#x0043a;&#x00430;&#x00441;&#x00430;&#x0044e;&#x00449;&#x00438;&#x0043c;&#x00441;&#x0044f; &#x00443;&#x0043f;&#x0043e;&#x00442;&#x00440;&#x00435;&#x00431;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00430;&#x0043b;&#x0043a;&#x0043e;&#x00433;&#x0043e;&#x0043b;&#x0044f;, &#x0043f;&#x0043e;&#x0043b;&#x00438;&#x0043c;&#x0043e;&#x00440;&#x00444;&#x00438;&#x00437;&#x0043c;&#x0043e;&#x00432; &#x00430;&#x0043b;&#x0044c;&#x00434;&#x00435;&#x00433;&#x00438;&#x00434;&#x00434;&#x00435;&#x00433;&#x00438;&#x00434;&#x00440;&#x0043e;&#x00433;&#x00435;&#x0043d;&#x00430;&#x00437;&#x0044b; &#x00438; &#x00440;&#x00438;&#x00441;&#x0043a;&#x00430; &#x00440;&#x00430;&#x00437;&#x00432;&#x00438;&#x00442;&#x00438;&#x0044f; &#x00440;&#x00430;&#x0043a;&#x00430; &#x0043f;&#x00438;&#x00449;&#x00435;&#x00432;&#x0043e;&#x00434;&#x00430; &#x00432; &#x0042f;&#x0043f;&#x0043e;&#x0043d;&#x00438;&#x00438;. &#x0041c;&#x0044b; &#x0043f;&#x00440;&#x0043e;&#x00432;&#x00435;&#x0043b;&#x00438; &#x0043c;&#x00435;&#x00442;&#x00430;&#x00430;&#x0043d;&#x00430;&#x0043b;&#x00438;&#x00437; &#x00441;&#x0043b;&#x00443;&#x00447;&#x00430;&#x00439;&#x0043d;&#x0044b;&#x00445; &#x0044d;&#x00444;&#x00444;&#x00435;&#x0043a;&#x00442;&#x0043e;&#x00432;, &#x00432;&#x0043a;&#x0043b;&#x0044e;&#x00447;&#x00430;&#x0044f; &#x00430;&#x0043d;&#x00430;&#x0043b;&#x00438;&#x00437;&#x0044b; &#x00432; &#x0043f;&#x0043e;&#x00434;&#x00433;&#x00440;&#x00443;&#x0043f;&#x0043f;&#x00430;&#x00445; &#x0043f;&#x0043e; &#x00432;&#x00430;&#x00440;&#x00438;&#x00430;&#x0043d;&#x00442;&#x00430;&#x0043c; &#x00430;&#x0043b;&#x0044c;&#x00434;&#x00435;&#x00433;&#x00438;&#x00434;&#x00434;&#x00435;&#x00433;&#x00438;&#x00434;&#x00440;&#x0043e;&#x00433;&#x00435;&#x0043d;&#x00430;&#x00437;&#x0044b;. &#x0041c;&#x0044b; &#x0043e;&#x00446;&#x00435;&#x0043d;&#x00438;&#x0043b;&#x00438; &#x0043a;&#x0043e;&#x0043b;&#x00438;&#x00447;&#x00435;&#x00441;&#x00442;&#x00432;&#x0043e; &#x00441;&#x0043c;&#x00435;&#x00440;&#x00442;&#x00435;&#x00439; &#x00438; &#x00443;&#x00442;&#x00440;&#x00430;&#x00447;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043b;&#x00435;&#x00442; &#x00436;&#x00438;&#x00437;&#x0043d;&#x00438; &#x00441; &#x0043f;&#x0043e;&#x0043f;&#x00440;&#x00430;&#x00432;&#x0043a;&#x0043e;&#x00439; &#x0043d;&#x00430; &#x00438;&#x0043d;&#x00432;&#x00430;&#x0043b;&#x00438;&#x00434;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x0044c; (&#x00413;&#x00416;&#x0041f;&#x00418;) &#x00432; &#x00440;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x00435; &#x00440;&#x00430;&#x0043a;&#x00430; &#x0043f;&#x00438;&#x00449;&#x00435;&#x00432;&#x0043e;&#x00434;&#x00430;, &#x00438;&#x00441;&#x0043f;&#x0043e;&#x0043b;&#x0044c;&#x00437;&#x00443;&#x0044f; &#x00440;&#x00430;&#x00441;&#x0043f;&#x00440;&#x00435;&#x00434;&#x00435;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x00435; &#x0043f;&#x0043e;&#x00434;&#x00432;&#x00435;&#x00440;&#x00433;&#x00430;&#x0044e;&#x00449;&#x00438;&#x00445;&#x00441;&#x0044f; &#x00432;&#x0043e;&#x00437;&#x00434;&#x00435;&#x00439;&#x00441;&#x00442;&#x00432;&#x00438;&#x0044e; &#x00430;&#x0043b;&#x0043a;&#x0043e;&#x00433;&#x0043e;&#x0043b;&#x0044f; &#x0043b;&#x00438;&#x00446; &#x0043f;&#x0043e; &#x00432;&#x0043e;&#x00437;&#x00440;&#x00430;&#x00441;&#x00442;&#x00443;, &#x0043f;&#x0043e;&#x0043b;&#x00443; &#x00438; &#x0043e;&#x00442;&#x0043d;&#x0043e;&#x00441;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x0043c;&#x00443; &#x00440;&#x00438;&#x00441;&#x0043a;&#x00443; &#x0043d;&#x00430; &#x00435;&#x00434;&#x00438;&#x0043d;&#x00438;&#x00446;&#x00443; &#x00432;&#x0043e;&#x00437;&#x00434;&#x00435;&#x00439;&#x00441;&#x00442;&#x00432;&#x00438;&#x0044f;.</p></sec><sec><title>&#x00420;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x0044b;</title><p>&#x0041c;&#x0044b; &#x00432;&#x0044b;&#x0044f;&#x00432;&#x00438;&#x0043b;&#x00438; 14&#x000a0;&#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439;, &#x00438;&#x0043c;&#x00435;&#x0044e;&#x00449;&#x00438;&#x00445; &#x0043e;&#x00442;&#x0043d;&#x0043e;&#x00448;&#x00435;&#x0043d;&#x00438;&#x00435; &#x0043a; &#x00432;&#x0043e;&#x0043f;&#x00440;&#x0043e;&#x00441;&#x00443;. &#x00414;&#x0043b;&#x0044f; &#x00442;&#x00440;&#x00435;&#x00445; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439; &#x00432; &#x0043a;&#x0043e;&#x00433;&#x0043e;&#x00440;&#x00442;&#x00430;&#x00445; &#x00438; &#x00447;&#x00435;&#x00442;&#x0044b;&#x00440;&#x00435;&#x00445; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439; &#x0043c;&#x00435;&#x00442;&#x0043e;&#x00434;&#x0043e;&#x0043c; &#x000ab;&#x00441;&#x0043b;&#x00443;&#x00447;&#x00430;&#x00439;-&#x0043a;&#x0043e;&#x0043d;&#x00442;&#x00440;&#x0043e;&#x0043b;&#x0044c;&#x000bb; &#x00431;&#x0044b;&#x0043b;&#x00438; &#x0043f;&#x00440;&#x00435;&#x00434;&#x00441;&#x00442;&#x00430;&#x00432;&#x0043b;&#x00435;&#x0043d;&#x0044b; &#x00434;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x0043e; &#x00437;&#x00430;&#x00432;&#x00438;&#x00441;&#x00438;&#x0043c;&#x0043e;&#x00441;&#x00442;&#x00438; &#x0043c;&#x00435;&#x00436;&#x00434;&#x00443; &#x00434;&#x0043e;&#x00437;&#x0043e;&#x00439; &#x00438; &#x0044d;&#x00444;&#x00444;&#x00435;&#x0043a;&#x00442;&#x0043e;&#x0043c;. &#x00414;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x0043a;&#x0043e;&#x00433;&#x0043e;&#x00440;&#x00442;&#x0043d;&#x0044b;&#x00445; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439; &#x00441;&#x00432;&#x00438;&#x00434;&#x00435;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x00441;&#x00442;&#x00432;&#x00443;&#x0044e;&#x00442; &#x0043e; &#x00442;&#x0043e;&#x0043c;, &#x00447;&#x00442;&#x0043e; &#x00443; &#x0043b;&#x00438;&#x00446;, &#x0043f;&#x0043e;&#x00442;&#x00440;&#x00435;&#x00431;&#x0043b;&#x0044f;&#x00432;&#x00448;&#x00438;&#x00445; &#x00430;&#x0043b;&#x0043a;&#x0043e;&#x00433;&#x0043e;&#x0043b;&#x0044c; &#x00432; &#x00434;&#x0043e;&#x00437;&#x00435;, &#x0044d;&#x0043a;&#x00432;&#x00438;&#x00432;&#x00430;&#x0043b;&#x00435;&#x0043d;&#x00442;&#x0043d;&#x0043e;&#x00439; 100&#x000a0;&#x00433; &#x00447;&#x00438;&#x00441;&#x00442;&#x0043e;&#x00433;&#x0043e; &#x00430;&#x0043b;&#x0043a;&#x0043e;&#x00433;&#x0043e;&#x0043b;&#x0044f; &#x00432; &#x00441;&#x00443;&#x00442;&#x0043a;&#x00438;, &#x00440;&#x00438;&#x00441;&#x0043a; &#x00440;&#x00430;&#x00437;&#x00432;&#x00438;&#x00442;&#x00438;&#x0044f; &#x00440;&#x00430;&#x0043a;&#x00430; &#x0043f;&#x00438;&#x00449;&#x00435;&#x00432;&#x0043e;&#x00434;&#x00430; &#x00432;&#x0043e;&#x00437;&#x00440;&#x00430;&#x00441;&#x00442;&#x00430;&#x00435;&#x00442; &#x00432; 11,71 &#x00440;&#x00430;&#x00437; (&#x00434;&#x0043e;&#x00432;&#x00435;&#x00440;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00439; &#x00438;&#x0043d;&#x00442;&#x00435;&#x00440;&#x00432;&#x00430;&#x0043b;, &#x00414;&#x00418; 95%: 2,67&#x02013;51,32) &#x0043f;&#x0043e; &#x00441;&#x00440;&#x00430;&#x00432;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044e; &#x00441; &#x0043b;&#x00438;&#x00446;&#x00430;&#x0043c;&#x00438;, &#x0043d;&#x00438;&#x0043a;&#x0043e;&#x00433;&#x00434;&#x00430; &#x0043d;&#x00435; &#x00443;&#x0043f;&#x0043e;&#x00442;&#x00440;&#x00435;&#x00431;&#x0043b;&#x0044f;&#x00432;&#x00448;&#x00438;&#x0043c;&#x00438; &#x00430;&#x0043b;&#x0043a;&#x0043e;&#x00433;&#x0043e;&#x0043b;&#x0044c;. &#x00414;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439; &#x0043c;&#x00435;&#x00442;&#x0043e;&#x00434;&#x0043e;&#x0043c; &#x000ab;&#x00441;&#x0043b;&#x00443;&#x00447;&#x00430;&#x00439;-&#x0043a;&#x0043e;&#x0043d;&#x00442;&#x00440;&#x0043e;&#x0043b;&#x0044c;&#x000bb; &#x00441;&#x00432;&#x00438;&#x00434;&#x00435;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x00441;&#x00442;&#x00432;&#x00443;&#x0044e;&#x00442; &#x0043e; &#x00442;&#x0043e;&#x0043c;, &#x00447;&#x00442;&#x0043e; &#x0043a;&#x00440;&#x00430;&#x00442;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x0044c; &#x0043f;&#x0043e;&#x00432;&#x0044b;&#x00448;&#x00435;&#x0043d;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x00440;&#x00438;&#x00441;&#x0043a;&#x00430; &#x00440;&#x00430;&#x00437;&#x00432;&#x00438;&#x00442;&#x00438;&#x0044f; &#x00437;&#x00430;&#x00431;&#x0043e;&#x0043b;&#x00435;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f; &#x00432;&#x0043e; &#x00432;&#x00441;&#x00435;&#x00439; &#x0043f;&#x0043e;&#x0043f;&#x00443;&#x0043b;&#x0044f;&#x00446;&#x00438;&#x00438; &#x00441;&#x0043e;&#x00441;&#x00442;&#x00430;&#x00432;&#x0043b;&#x0044f;&#x00435;&#x00442; 33,11 (&#x00414;&#x00418; 95%: 8,15&#x02013;134,43). &#x00420;&#x00430;&#x00437;&#x0043d;&#x00438;&#x00446;&#x00430; &#x00432; &#x0043f;&#x0043b;&#x00430;&#x0043d;&#x00435; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f; &#x0043e;&#x00431;&#x0044a;&#x0044f;&#x00441;&#x0043d;&#x0044f;&#x00435;&#x00442;&#x00441;&#x0044f; &#x0043a;&#x00440;&#x00430;&#x00442;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x0044c;&#x0044e; &#x00440;&#x00438;&#x00441;&#x0043a;&#x00430; 159 (&#x00414;&#x00418; 95%: 27,2&#x02013;938,2) &#x00434;&#x0043b;&#x0044f; &#x0043b;&#x00438;&#x00446; &#x00441; &#x0043d;&#x00435;&#x00430;&#x0043a;&#x00442;&#x00438;&#x00432;&#x0043d;&#x0044b;&#x0043c; &#x00432;&#x00430;&#x00440;&#x00438;&#x00430;&#x0043d;&#x00442;&#x0043e;&#x0043c; &#x00444;&#x00435;&#x00440;&#x0043c;&#x00435;&#x0043d;&#x00442;&#x00430; &#x00430;&#x0043b;&#x0044c;&#x00434;&#x00435;&#x00433;&#x00438;&#x00434;&#x00434;&#x00435;&#x00433;&#x00438;&#x00434;&#x00440;&#x0043e;&#x00433;&#x00435;&#x0043d;&#x00430;&#x00437;&#x0044b;. &#x0041f;&#x00440;&#x00438;&#x0043c;&#x00435;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x00435; &#x00442;&#x00430;&#x0043a;&#x00438;&#x00445; &#x0043e;&#x00446;&#x00435;&#x0043d;&#x0043e;&#x0043a; &#x00434;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043e; &#x00437;&#x00430;&#x00432;&#x00438;&#x00441;&#x00438;&#x0043c;&#x0043e;&#x00441;&#x00442;&#x00438; &#x0043c;&#x00435;&#x00436;&#x00434;&#x00443; &#x00434;&#x0043e;&#x00437;&#x0043e;&#x00439; &#x00438; &#x0044d;&#x00444;&#x00444;&#x00435;&#x0043a;&#x00442;&#x0043e;&#x0043c; &#x0043a; &#x0043d;&#x00430;&#x00446;&#x00438;&#x0043e;&#x0043d;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x0043c;&#x00443; &#x0043f;&#x00440;&#x0043e;&#x00444;&#x00438;&#x0043b;&#x0044e; &#x0043f;&#x0043e;&#x00442;&#x00440;&#x00435;&#x00431;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00430;&#x0043b;&#x0043a;&#x0043e;&#x00433;&#x0043e;&#x0043b;&#x0044f; &#x0043f;&#x0043e;&#x00437;&#x00432;&#x0043e;&#x0043b;&#x00438;&#x0043b;&#x0043e; &#x0043f;&#x0043e;&#x0043b;&#x00443;&#x00447;&#x00438;&#x00442;&#x0044c; 5&#x000a0;279&#x000a0;&#x00441;&#x0043c;&#x00435;&#x00440;&#x00442;&#x00435;&#x00439; &#x0043e;&#x00442; &#x00440;&#x00430;&#x0043a;&#x00430; &#x0043f;&#x00438;&#x00449;&#x00435;&#x00432;&#x0043e;&#x00434;&#x00430; &#x00438; 102&#x000a0;988 &#x00443;&#x00442;&#x00440;&#x00430;&#x00447;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00413;&#x00416;&#x0041f;&#x00418;, &#x00447;&#x00442;&#x0043e; &#x0043f;&#x0043e;&#x00447;&#x00442;&#x00438; &#x00432; &#x00434;&#x00432;&#x00430; &#x00440;&#x00430;&#x00437;&#x00430; &#x0043f;&#x00440;&#x00435;&#x00432;&#x0044b;&#x00448;&#x00430;&#x00435;&#x00442; &#x00440;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x0044b; &#x0043f;&#x0043e;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043d;&#x00438;&#x00445; &#x0043c;&#x00435;&#x00436;&#x00434;&#x00443;&#x0043d;&#x00430;&#x00440;&#x0043e;&#x00434;&#x0043d;&#x0044b;&#x00445; &#x0043e;&#x00446;&#x00435;&#x0043d;&#x0043e;&#x0043a; &#x00431;&#x00440;&#x00435;&#x0043c;&#x00435;&#x0043d;&#x00438; &#x00434;&#x00430;&#x0043d;&#x0043d;&#x0043e;&#x00439; &#x00431;&#x0043e;&#x0043b;&#x00435;&#x00437;&#x0043d;&#x00438;.</p></sec><sec><title>&#x00412;&#x0044b;&#x00432;&#x0043e;&#x00434;</title><p>&#x00418;&#x00441;&#x0043f;&#x0043e;&#x0043b;&#x0044c;&#x00437;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00435; &#x00434;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043e; &#x00437;&#x00430;&#x00432;&#x00438;&#x00441;&#x00438;&#x0043c;&#x0043e;&#x00441;&#x00442;&#x00438; &#x0043c;&#x00435;&#x00436;&#x00434;&#x00443; &#x00434;&#x0043e;&#x00437;&#x0043e;&#x00439; &#x00438; &#x0044d;&#x00444;&#x00444;&#x00435;&#x0043a;&#x00442;&#x0043e;&#x0043c;, &#x0043f;&#x0043e;&#x0043b;&#x00443;&#x00447;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043f;&#x0043e; &#x00440;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x00430;&#x0043c; &#x0043c;&#x00435;&#x00436;&#x00434;&#x00443;&#x0043d;&#x00430;&#x00440;&#x0043e;&#x00434;&#x0043d;&#x0044b;&#x00445; &#x0043e;&#x00446;&#x00435;&#x0043d;&#x0043e;&#x0043a;, &#x0043f;&#x00440;&#x00438;&#x00432;&#x0043e;&#x00434;&#x00438;&#x00442; &#x0043a; &#x0043d;&#x00435;&#x00434;&#x0043e;&#x0043e;&#x00446;&#x00435;&#x0043d;&#x0043a;&#x00435; &#x00431;&#x00440;&#x00435;&#x0043c;&#x00435;&#x0043d;&#x00438; &#x00440;&#x00430;&#x0043a;&#x00430; &#x0043f;&#x00438;&#x00449;&#x00435;&#x00432;&#x0043e;&#x00434;&#x00430; &#x00432; &#x0042f;&#x0043f;&#x0043e;&#x0043d;&#x00438;&#x00438;. &#x00412; &#x00441;&#x00438;&#x00442;&#x00443;&#x00430;&#x00446;&#x00438;&#x0044f;&#x00445;, &#x0043a;&#x0043e;&#x00433;&#x00434;&#x00430; &#x0044d;&#x00442;&#x0043e; &#x00432;&#x0043e;&#x00437;&#x0043c;&#x0043e;&#x00436;&#x0043d;&#x0043e;, &#x00434;&#x0043b;&#x0044f; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439; &#x0043f;&#x0043e; &#x00440;&#x00430;&#x00441;&#x00447;&#x00435;&#x00442;&#x00443; &#x00431;&#x00440;&#x00435;&#x0043c;&#x00435;&#x0043d;&#x00438; &#x00437;&#x00430;&#x00431;&#x0043e;&#x0043b;&#x00435;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f; &#x0043d;&#x00430; &#x00443;&#x00440;&#x0043e;&#x00432;&#x0043d;&#x00435; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x0044b; &#x00441;&#x0043b;&#x00435;&#x00434;&#x00443;&#x00435;&#x00442; &#x00438;&#x00441;&#x0043f;&#x0043e;&#x0043b;&#x0044c;&#x00437;&#x0043e;&#x00432;&#x00430;&#x00442;&#x0044c; &#x00440;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x0044b;, &#x0043a;&#x00430;&#x00441;&#x00430;&#x0044e;&#x00449;&#x00438;&#x00435;&#x00441;&#x0044f; &#x0043a;&#x0043e;&#x0043d;&#x0043a;&#x00440;&#x00435;&#x00442;&#x0043d;&#x0043e;&#x00439; &#x0043f;&#x0043e;&#x0043f;&#x00443;&#x0043b;&#x0044f;&#x00446;&#x00438;&#x00438;.</p></sec></trans-abstract></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Alcohol consumption is a major contributor to the global burden of disease<xref rid="R1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="R2" ref-type="bibr"><sup>2</sup></xref> and is a major risk factor for cancer.<xref rid="R3" ref-type="bibr"><sup>3</sup></xref><sup>&#x02013;</sup><xref rid="R6" ref-type="bibr"><sup>6</sup></xref> Of all alcohol-related cancers, oesophageal has the highest alcohol-attributable fraction<xref rid="R6" ref-type="bibr"><sup>6</sup></xref> &#x02013; i.e. the highest proportion of these cancers would be prevented if no alcohol were consumed.<xref rid="R6" ref-type="bibr"><sup>6</sup></xref><sup>&#x02013;</sup><xref rid="R8" ref-type="bibr"><sup>8</sup></xref> The global burden of disease (GBD) study estimates that in 2010 alcohol-attributable oesophageal cancer resulted in 76&#x02009;700 deaths and 1&#x02009;825&#x02009;000 disability adjusted life years (DALYs) lost, globally.<xref rid="R9" ref-type="bibr"><sup>9</sup></xref></p><p>A large portion of oesophageal cancers attributable to alcohol consumption occur in Asian countries &#x02013; 52.2% (40&#x02009;000) of all alcohol-attributable oesophageal cancer deaths and 51.8% (945&#x02009;000) of all alcohol-attributable oesophageal cancer DALYs. The alcohol-attributable portions for countries in this region have been calculated based on global meta-analyses.<xref rid="R10" ref-type="bibr"><sup>10</sup></xref><sup>,</sup><xref rid="R11" ref-type="bibr"><sup>11</sup></xref> However, this assumes that the alcohol-attributable risk for oesophageal cancer is the same in all regions. Preliminary evidence, on the other hand, shows that the risk for this cancer is different for people of Asian origin, because of genetic polymorphisms &#x02013; most importantly the aldehyde dehydrogenase 2 (<italic>ALDH2</italic>) and alcohol dehydrogenase 1B (<italic>ADH1B</italic>) polymorphisms.<xref rid="R12" ref-type="bibr"><sup>12</sup></xref><sup>&#x02013;</sup><xref rid="R15" ref-type="bibr"><sup>15</sup></xref> Thus, the real risk and burden of alcohol-attributable oesophageal cancer in Asia may have been underestimated.</p><p>In Japan in 2010, oesophageal cancer was among the top 20 causes of years of life lost (11 deaths and 181 DALYs per 100&#x02009;000 people per year).<xref rid="R9" ref-type="bibr"><sup>9</sup></xref> We did a systematic review and meta-analyses of studies conducted in the Japanese population to estimate the alcohol-attributable burden of oesophageal cancer. We then compared these estimates to the GBD 2010 estimates.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> We also estimated risk functions according to <italic>ALDH2</italic> subsets and investigated potential interactions between <italic>ALDH2</italic> and <italic>ADH1B</italic> polymorphisms.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Data search and selection</title><p>We followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines.<xref rid="R16" ref-type="bibr"><sup>16</sup></xref> We used the latest editions of the International Agency for Research on Cancer (IARC) monographs on alcohol<xref rid="R3" ref-type="bibr"><sup>3</sup></xref><sup>,</sup><xref rid="R4" ref-type="bibr"><sup>4</sup></xref> to identify potentially eligible studies. Additionally, we searched PubMed for publications published before 2014. We did two searches using the following search terms; Search 1: &#x0201c;cancer or neoplasm or carcinom*&#x0201d; and &#x0201c;<italic>ALDH2</italic> or <italic>ADH1B</italic> or <italic>ADH2</italic> or <italic>ADH3</italic> or <italic>ADH1C</italic> or dehydrogenase*&#x0201d; and &#x0201c;alcohol or ethanol&#x0201d;; Search 2: &#x0201c;alcohol or ethanol&#x0201d; and &#x0201c;cohort&#x0201d; and &#x0201c;cancer&#x0201d; and &#x0201c;japan&#x0201d; and &#x0201c;review&#x0201d; and &#x0201c;mortality&#x0201d;. Inclusion criteria for analyses investigating the relationship between alcohol consumption, <italic>ALDH2</italic>, and oesophageal cancer were: (i)&#x000a0;prospective or historical cohort or case-control study design; (ii)&#x000a0;a measure of risk and its corresponding measure of variability was reported or there were sufficient data for us to calculate these; (iii)&#x000a0;oesophageal cancer was reported as a separate outcome; (iv)&#x000a0;data on total alcohol intake for at least two exposure categories among current drinkers, or estimates for <italic>ALDH2</italic> variants by alcohol intake were reported; (v)&#x000a0;risk estimates were at least age-adjusted; and (vi)&#x000a0;the study was conducted in Japan after 1980. In addition, we searched reference lists of identified articles for additional articles. No active filters or language restrictions were applied. We excluded measures of pure drinking frequency and qualitative characteristics &#x02013; such as social or problem drinker. Oesophageal cancer cases (<italic>International Classification of Diseases</italic> [ICD] version 9: 150, ICD-10: C15) were defined as newly diagnosed at the first visit to a specialized clinic, through cancer registries or cause of death on death certificates.</p><p>Most quality scores for primary studies are tailored for meta-analyses of randomized trials of interventions<xref rid="R17" ref-type="bibr"><sup>17</sup></xref><sup>&#x02013;</sup><xref rid="R19" ref-type="bibr"><sup>19</sup></xref> and many criteria for such scores do not apply to epidemiological studies examined in this study. Additionally, quality score use in meta-analyses remains controversial.<xref rid="R19" ref-type="bibr"><sup>19</sup></xref><sup>,</sup><xref rid="R20" ref-type="bibr"><sup>20</sup></xref> As a result, we included quality components in the inclusion and exclusion criteria of the systematic search and separate meta-analyses &#x02013; such as study design and alcohol measurement &#x02013; and conducted subgroup analyses based on study design and genetic polymorphisms.</p></sec><sec><title>Data extraction</title><p>From all relevant articles we extracted: authors&#x02019; names, year of publication, country, calendar year(s) of baseline examination, follow-up period, setting, assessment of oesophageal cancer diagnosis, range of age at baseline, sex, number of observed oesophageal cancer cases among participants by alcohol exposure category, number of total participants by alcohol exposure category, adjustment for potential confounders and effect size with its standard error. We used the most fully adjusted effect size reported and selected estimates where lifetime abstainers were used as the risk reference group when those were available. Assessment of full-text articles with uncertain eligibility and data abstraction were conducted independently by two authors who discussed differences until consensus was reached. When there was not enough information presented in the article, we contacted the corresponding author.</p><p>We converted alcohol intake into grams of pure alcohol per day (g/day) using the midpoints (mean) of reported categories in the studies. For open-ended categories of alcohol intake, we added three-fourths of the previous category&#x02019;s range to the lower bound of the open-ended categories. We used reported conversion factors in the studies when standard drinks were the unit of measurement. Hazard ratios and odds ratios were assumed to be equivalent to relative risks (RR). We used fractional polynomials<xref rid="R21" ref-type="bibr"><sup>21</sup></xref> to derive the best fitting function for average alcohol consumption in g/day using the pool-first approach described by Orsini et al.<xref rid="R22" ref-type="bibr"><sup>22</sup></xref> Linear and first-degree models were estimated using the following range of powers: &#x02212;2, &#x02212;1, 0, 1, 2, 3.<xref rid="R21" ref-type="bibr"><sup>21</sup></xref> Significant increases in deviance were determined by likelihood ratio tests with one degree of freedom.</p></sec><sec><title>Data analyses</title><p>We conducted several meta-analyses and used the most comprehensive data available separately for each analysis when multiple reports from the same cohort were published. For studies providing data on two or more alcohol intake categories among current drinkers, we pooled data from (i)&#x000a0;cohort studies; (ii)&#x000a0;case-control studies; (iii)&#x000a0;case-control studies that provided stratified data by <italic>ALDH2</italic> variants. We conducted sensitivity analyses on the interaction between variants of <italic>ADH1B</italic> within the genetic variants of <italic>ALDH2.</italic> In analyses investigating <italic>ALDH2</italic> variants, studies were pooled separately for the active variant (<italic>ALDH2*1/*1</italic>) and inactive variants (<italic>ALDH2*1/*2 and ALDH2*2/*2</italic>). No cohort studies provided <italic>ALDH2</italic> genotype data. Where possible, we avoided <italic>ALDH2*2/*2</italic> variants because of the low number of cases. No systematic information on the distribution of <italic>ALDH2</italic> variants by drinking level was available and we therefore used the distribution of drinking by <italic>ALDH2</italic> variants among controls in case-control studies to estimate this distribution at the population level. Finally, studies were pooled using DerSimonian-Laird random-effect models to allow for between-study heterogeneity.<xref rid="R23" ref-type="bibr"><sup>23</sup></xref> Variation in the effect size other than chance because of heterogeneity between studies was quantified using the <italic>I<sup>2</sup></italic> statistic.<xref rid="R24" ref-type="bibr"><sup>24</sup></xref> We conducted meta-regression analyses to identify study characteristics that influenced the association between alcohol consumption and oesophageal cancer risk. Because of few available studies, we were only able to investigate study design in such meta-regression analyses. Examination of potential publication bias using Egger&#x02019;s regression-based test<xref rid="R25" ref-type="bibr"><sup>25</sup></xref> was planned, but was not done because of the few studies included. All meta-analyses were conducted on the natural log scale in Stata statistical software, version 12.1 (StataCorp. LP, College Station, United States of America) and <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 (two-sided) was considered statistically significant.</p><p>We estimated deaths and DALYs lost from oesophageal cancer attributable to alcohol consumption in Japan applying a standardized alcohol-attributable fraction method<xref rid="R26" ref-type="bibr"><sup>26</sup></xref> using the statistical software package R, version 3.0.3 (R Foundation for Statistical Computing, Vienna, Austria). These deaths and DALYs were estimated by comparing the risk difference of oesophageal cancer under current conditions compared to the risk of oesophageal cancer under the theoretical-minimum-risk exposure scenario where no one has consumed alcohol.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="R7" ref-type="bibr"><sup>7</sup></xref> These calculations combine information on the prevalence of alcohol consumption adjusted for per capita consumption and RRs for oesophageal cancer. Lifetime abstainers were used as the reference group and compared to former drinkers and current drinkers &#x02013; by average daily alcohol consumption. Data on alcohol drinking status were obtained from the 2010 GBD study,<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> where data on drinking status were based on data from large population surveys. Data on per capita consumption were from the Global Information System on Alcohol and Health.<xref rid="R27" ref-type="bibr"><sup>27</sup></xref> Calculations for Japan were based on RRs from this study and RRs for GBD estimates for Japan were based on Corrao et al.<xref rid="R11" ref-type="bibr"><sup>11</sup></xref></p></sec></sec><sec sec-type="results"><title>Results</title><p>After removal of duplicates, we evaluated 1333 records for inclusion in our study. Based on titles and abstracts, we excluded 1174 articles and screened 159 in full-text articles (<xref ref-type="fig" rid="F1">Fig.&#x000a0;1</xref>). After excluding duplicate reports of the same cohorts, we analysed 11 case-control studies<xref rid="R28" ref-type="bibr"><sup>28</sup></xref><sup>&#x02013;</sup><xref rid="R38" ref-type="bibr"><sup>38</sup></xref> and 3 cohort studies.<xref rid="R39" ref-type="bibr"><sup>39</sup></xref><sup>&#x02013;</sup><xref rid="R41" ref-type="bibr"><sup>41</sup></xref> Eight case-control and cohort studies<xref rid="R32" ref-type="bibr"><sup>32</sup></xref><sup>&#x02013;</sup><xref rid="R36" ref-type="bibr"><sup>36</sup></xref><sup>,</sup><xref rid="R39" ref-type="bibr"><sup>39</sup></xref><sup>&#x02013;</sup><xref rid="R41" ref-type="bibr"><sup>41</sup></xref> reported estimates for at least two alcohol intake categories in comparison to non-drinkers. These studies were used for a nonlinear dose&#x02013;response analysis of oesophageal cancer risk, including stratified analyses by <italic>ALDH2</italic> variants. Four case-control studies<xref rid="R28" ref-type="bibr"><sup>28</sup></xref><sup>&#x02013;</sup><xref rid="R31" ref-type="bibr"><sup>31</sup></xref> provided indirect evidence for only one alcohol intake category <xref ref-type="table" rid="T1">Table&#x000a0;1</xref> (available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/bulletin/volumes/93/5/14-142141">http://www.who.int/bulletin/volumes/93/5/14-142141</ext-link>). In total five studies had data on <italic>ALDH2</italic> and <italic>ADH1B</italic> variants stratified or adjusted by level of alcohol consumption.<xref rid="R29" ref-type="bibr"><sup>29</sup></xref><sup>,</sup><xref rid="R31" ref-type="bibr"><sup>31</sup></xref><sup>,</sup><xref rid="R36" ref-type="bibr"><sup>36</sup></xref><sup>&#x02013;</sup><xref rid="R38" ref-type="bibr"><sup>38</sup></xref></p><fig id="F1" fig-type="figure" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Flowchart for the selection of studies on alcohol consumption and oesophageal cancer in Japan</p></caption><p>ADH1B: alcohol dehydrogenase 1B; ALDH2: aldehyde dehydrogenase 2.</p><graphic xlink:href="BLT.14.142141-F1"/></fig><table-wrap id="T1" specific-use="online" orientation="portrait" position="float"><label>Table 1</label><caption><title>Summary of studies assessing the relationship between alcohol and oesophageal cancer in Japan</title></caption><table frame="hsides" rules="groups"><col width="62" span="1"/><col width="60" span="1"/><col width="115" span="1"/><col width="78" span="1"/><col width="98" span="1"/><col width="114" span="1"/><col width="121" span="1"/><col width="94" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Study and year</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Study design (follow-up)</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Setting</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Study period, age and sex</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">No. of cases and controls</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Case and control identification</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Alcohol assessment</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Adjustment</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Yokoyama et al., 1998<xref rid="R28" ref-type="bibr"><sup>28</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Case-control</td><td valign="top" align="left" rowspan="1" colspan="1">National Institute on Alcoholism, Kurihama National Hospital</td><td valign="top" align="left" rowspan="1" colspan="1">1987&#x02013;1997, &#x02265;&#x02009;40 years, men</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: 87, whereof <italic>ALDH2*1/*1</italic>: 41, <italic>ALDH2*1/*2</italic> and <italic>ALDH2*2/*2</italic>: 46<break/>Controls: 487</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: SCC histologically diagnosed at alcohol treatment entry or before onset of alcoholism<break/>Controls: cancer-free alcoholics</td><td valign="top" align="left" rowspan="1" colspan="1">Alcohol dependence (DSM-III), mean alcohol intake 123&#x000a0;g/day</td><td valign="top" align="left" rowspan="1" colspan="1">Age at admission to alcohol treatment, daily alcohol consumption, number of cigarettes</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Takezaki et al., 2000<xref rid="R35" ref-type="bibr"><sup>35</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Case-control</td><td valign="top" align="left" rowspan="1" colspan="1">Aichi Cancer Centre</td><td valign="top" align="left" rowspan="1" colspan="1">1988&#x02013;1997, 40&#x02013;79 years, men</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: 284<break/>Controls: 11&#x02009;384 (former alcohol drinkers were excluded in the analysis)</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: first out-visit outpatients diagnosed with primary cancer of the oesophagus (ICD-9: 150, ICD-10: C15)<break/>Controls: first-visit outpatients confirmed to be cancer-free (including no history of cancer assessed by questionnaire)</td><td valign="top" align="left" rowspan="1" colspan="1">Drinking levels: never or occasionally, former drinkers, current drinkers &#x0003c;&#x02009;1.5 drinks/day, &#x02265;&#x02009;1.5 drinks/day. One drink&#x02009;=&#x02009;1&#x000a0;<italic>go</italic> (Japanese sake with 27&#x000a0;mL ethanol)</td><td valign="top" align="left" rowspan="1" colspan="1">Age, year and season of visit, smoking (never, former, current, &#x0003c;&#x02009;30 and &#x02265;&#x02009;30 pack-years), consumption of raw vegetables</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Yokoyama et al., 2001<xref rid="R29" ref-type="bibr"><sup>29</sup></xref><sup>,a</sup></td><td valign="top" align="left" rowspan="1" colspan="1">Case-control</td><td valign="top" align="left" rowspan="1" colspan="1">National Institute on Alcoholism, Kurihama National Hospital</td><td valign="top" align="left" rowspan="1" colspan="1">1993&#x02013;2000, &#x02265;&#x02009;40 years, men</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: 112, whereof <italic>ALDH2*1/*1</italic>: 50, <italic>ALDH2*1/*2</italic> and <italic>ALDH2*2/*2</italic>: 62<break/>Controls: 526</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: SCC histologically diagnosed at alcohol treatment entry or before onset of alcoholism<break/>Controls: cancer-free alcoholics</td><td valign="top" align="left" rowspan="1" colspan="1">Alcohol dependence (DSM-III), mean alcohol intake 123&#x000a0;g/day</td><td valign="top" align="left" rowspan="1" colspan="1">Age at admission to alcohol treatment, daily alcohol consumption, number of cigarettes</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Matsuo et al., 2001<xref rid="R30" ref-type="bibr"><sup>30</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Case-control</td><td valign="top" align="left" rowspan="1" colspan="1">Aichi Cancer Centre</td><td valign="top" align="left" rowspan="1" colspan="1">1984&#x02013;2000, 40&#x02013;76 years, women and men</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: 102, whereof <italic>ALDH2*1/*1</italic>: 35, <italic>ALDH2*1/*2</italic>: 66, <italic>ALDH2*2/*2</italic>: 1<break/>Controls: 241</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: first diagnosis for oesophageal cancer<break/>Controls: first-visit outpatients confirmed by gastroscopy to have no oesophagus or stomach cancer</td><td valign="top" align="left" rowspan="1" colspan="1">Drinking status (2 categories): &#x0003e;&#x02009;3&#x000a0;<italic>go</italic> (Japanese sake with 75&#x000a0;mL pure alcohol)/day &#x02265;&#x02009;5 times per week, and all others (non-drinkers and drinkers with &#x02264;&#x02009;3&#x000a0;<italic>go</italic> per day and &#x0003c;&#x02009;5 times per week)</td><td valign="top" align="left" rowspan="1" colspan="1">Age, smoking (never, former, current, &#x0003c;&#x02009;30 and &#x02265;&#x02009;30 pack-years), consumption of raw vegetables</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Yokoyama et al., 2002<xref rid="R36" ref-type="bibr"><sup>36</sup></xref><sup>,a</sup></td><td valign="top" align="left" rowspan="1" colspan="1">Case-control</td><td valign="top" align="left" rowspan="1" colspan="1">National Cancer Centre Hospital, National cancer Centre Hospital East, Kawasaki Municipal Hospital, National Osaka Hospital</td><td valign="top" align="left" rowspan="1" colspan="1">2000&#x02013;2001, 40&#x02013;79 years, men</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: 220 SCC, whereof <italic>ALDH2*1/*1</italic>: 60, <italic>ALDH2*1*2</italic>: 160<break/>Controls: 590</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: SCC newly diagnosed by histology within 3&#x000a0;years before registration in study<break/>Controls: cancer-free men who visited two Tokyo clinics for annual health check-up</td><td valign="top" align="left" rowspan="1" colspan="1">Drinking levels: non- or rare drinkers, former drinkers, current drinkers 1&#x02013;8.9&#x000a0;U/week, 9&#x02013;17.9&#x000a0;U/week, &#x02265;&#x02009;18&#x000a0;U/week. U&#x02009;=&#x02009;unit of alcohol (1 serving of sake, 22&#x000a0;g pure alcohol/U)</td><td valign="top" align="left" rowspan="1" colspan="1">Age, frequency of drinking strong alcoholic beverages, smoking (pack years), intake frequency of green-yellow vegetables, intake frequency of fruits</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Yokoyama et al., 2003<xref rid="R32" ref-type="bibr"><sup>32</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Case-control</td><td valign="top" align="left" rowspan="1" colspan="1">National Cancer Centre Hospital, National cancer Centre Hospital East, Kawasaki Municipal Hospital, National Osaka Hospital</td><td valign="top" align="left" rowspan="1" colspan="1">2000&#x02013;2001, 40&#x02013;79 years, men</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: 220 SCC<break/>Controls: 598 (former alcohol drinkers were excluded in the analysis)</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: SCC newly diagnosed by histology within 3&#x000a0;years before registration in study<break/>Controls: cancer-free men who visited two Tokyo clinics for annual health check-ups</td><td valign="top" align="left" rowspan="1" colspan="1">Drinking levels: non- or rare drinkers, former drinkers, current drinkers 1&#x02013;8.9&#x000a0;U/week, 9&#x02013;17.9&#x000a0;U/week, &#x02265;&#x02009;18&#x000a0;U/week. U&#x02009;=&#x02009;unit of alcohol (1 serving of sake, 22&#x000a0;g pure alcohol/U)</td><td valign="top" align="left" rowspan="1" colspan="1">Age, frequency of drinking strong alcoholic beverages, smoking (pack years), intake frequency of green-yellow vegetables, intake frequency of fruits</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Nakaya et al., 2005<xref rid="R40" ref-type="bibr"><sup>40</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Cohort (7&#x000a0;years follow-up)</td><td valign="top" align="left" rowspan="1" colspan="1">Miyagi II</td><td valign="top" align="left" rowspan="1" colspan="1">1990&#x02013;1997, 40&#x02013;64 years, men</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: 48 among 19&#x02009;607 participants (former alcohol drinkers were excluded in the analysis)</td><td valign="top" align="left" rowspan="1" colspan="1">Cases were identified via record linkage to cancer registry</td><td valign="top" align="left" rowspan="1" colspan="1">Drinking levels: five categories based on drinking frequency and amount per occasion: never, former-drinkers, current drinkers &#x0003c;&#x02009;22.8&#x000a0;g pure alcohol/day, 22.8&#x02013;45.5&#x000a0;g/day, and &#x02265;&#x02009;45.6&#x000a0;g/day</td><td valign="top" align="left" rowspan="1" colspan="1">Age, smoking (never, former, current 1&#x02013;19 cigarettes per day, 20&#x02013;29 per day, 30 or more per day), education, daily consumption of orange and other fruit juice, spinach, carrot or pumpkin, and tomato</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Yokoyama et al., 2006<xref rid="R33" ref-type="bibr"><sup>33</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Case-control</td><td valign="top" align="left" rowspan="1" colspan="1">National Cancer Centre Hospital, National cancer centre Hospital East, Kawasaki Municipal Hospital, National Osaka Hospital</td><td valign="top" align="left" rowspan="1" colspan="1">2000&#x02013;2004, 40&#x02013;79 years, women</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: 43 SCC, whereof <italic>ALDH2*1/*1</italic>: 25, <italic>ALDH2*1/*2</italic>: 18<break/>Controls: 365</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: SCC newly diagnosed by histology within 3&#x000a0;years before registration in study<break/>Controls: cancer-free women who visited two Tokyo clinics for annual health check-up</td><td valign="top" align="left" rowspan="1" colspan="1">Drinking levels: non- or rare drinkers, former drinkers, current drinkers 1&#x02013;8.9&#x000a0;U/week, 9&#x02013;17.9&#x000a0;U/week, &#x02265;&#x02009;18&#x000a0;U/week. U&#x02009;=&#x02009;unit of alcohol (1 serving of sake, 22&#x000a0;g pure alcohol/U)</td><td valign="top" align="left" rowspan="1" colspan="1">Age, smoking (pack years), intake frequency of green-yellow vegetables, intake frequency of fruits, preference for hot food or drinks</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ozasa et al., 2007<xref rid="R41" ref-type="bibr"><sup>41</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Cohort (not reported)</td><td valign="top" align="left" rowspan="1" colspan="1">JACC</td><td valign="top" align="left" rowspan="1" colspan="1">1988&#x02013;1990, 40&#x02013;79 years, men</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: 117 among 42&#x02009;578 participants (former alcohol drinkers were excluded)</td><td valign="top" align="left" rowspan="1" colspan="1">Death certificates (ICD-10: C15)</td><td valign="top" align="left" rowspan="1" colspan="1">Drinking levels: non- or rare drinkers, former drinkers, current drinkers &#x0003c;&#x02009;54&#x000a0;mL pure alcohol/day, 54&#x02013;80&#x000a0;mL/day, &#x02265;&#x02009;81&#x000a0;mL/day</td><td valign="top" align="left" rowspan="1" colspan="1">Age, study area</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cui et al., 2009<xref rid="R31" ref-type="bibr"><sup>31</sup></xref><sup>,a</sup></td><td valign="top" align="left" rowspan="1" colspan="1">Case-control</td><td valign="top" align="left" rowspan="1" colspan="1">Biobank Japan</td><td valign="top" align="left" rowspan="1" colspan="1">2003&#x02013;2008, 35&#x02013;85 years, men and women</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: 1&#x02009;066, whereof <italic>ALDH2*1/*2</italic>: 735, <italic>ALDH2*1/*1</italic> and <italic>ALDH2*2/*2</italic>: 331<break/>Controls: 2&#x02009;761</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: histologically diagnosed SCC<break/>Controls: volunteers or registered in Biobank for diseases other than cancer</td><td valign="top" align="left" rowspan="1" colspan="1">Drinking status: none/rare (0&#x02013;96.5&#x000a0;g pure alcohol/week), and other drinkers (&#x02265;&#x02009;96.5&#x000a0;g/week)</td><td valign="top" align="left" rowspan="1" colspan="1">Age, gender (analyses among heavy alcohol consumers, &#x0003e;&#x02009;96.5&#x000a0;g/week)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ishiguro et al., 2009<xref rid="R39" ref-type="bibr"><sup>39</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Cohort (14 years follow-up)</td><td valign="top" align="left" rowspan="1" colspan="1">JPHC I+II</td><td valign="top" align="left" rowspan="1" colspan="1">1990 and 1993, 40&#x02013;59 years, men</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: 215 SCC among 60&#x02009;876 participants</td><td valign="top" align="left" rowspan="1" colspan="1">Active patient notification from hospital and linkage to Cancer Registry (ICD-0&#x02013;3: C15.0&#x02013;15.9)</td><td valign="top" align="left" rowspan="1" colspan="1">Drinking levels: non-drinkers, less than weekly drinking (frequency only), 1&#x02013;149&#x000a0;g pure alcohol /week, 150&#x02013;299&#x000a0;g/week, &#x02265;&#x02009;300&#x000a0;g/week</td><td valign="top" align="left" rowspan="1" colspan="1">Age, study area, body mass index, preference for spicy food and drinks, smoking status (never, past, current), flushing response</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Oze et al., 2010<xref rid="R34" ref-type="bibr"><sup>34</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Case-control</td><td valign="top" align="left" rowspan="1" colspan="1">Aichi Cancer Centre</td><td valign="top" align="left" rowspan="1" colspan="1">2001&#x02013;2005, &#x02265;&#x02009;18 years, men and women</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: 260, whereof <italic>ALDH2*1/*1</italic>: 67, <italic>ALDH2*1/*2</italic> and <italic>ALDH2*2/*2</italic>: 198<break/>Controls: 487</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: first out-visit outpatients diagnosed with primary cancer of the oesophagus (ICD-10: C15)<break/>Controls: First-visit outpatients confirmed to be cancer-free (including no history of cancer assessed by questionnaire)</td><td valign="top" align="left" rowspan="1" colspan="1">Drinking levels: never, moderate (&#x02264;&#x02009;4&#x000a0;days/week), high-moderate (&#x02265;&#x02009;5&#x000a0;days/week and &#x0003c;&#x02009;46 g pure alcohol/occasion), heavy (&#x02265;&#x02009;5&#x000a0;days/week and &#x02265;&#x02009;46 g/occasion)</td><td valign="top" align="left" rowspan="1" colspan="1">Frequency matched by age group (&#x0003c;&#x02009;40, 40&#x02013;49, 50&#x02013;59, 60&#x02013;69, &#x02265;&#x02009;70 years) and sex. Adjustment for cumulative smoking, facial flushing, fruit and vegetable intake, frequent intake of hot beverages and body mass index</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Yang et al., 2005<xref rid="R37" ref-type="bibr"><sup>37</sup></xref><sup>,a</sup></td><td valign="top" align="left" rowspan="1" colspan="1">Case-control</td><td valign="top" align="left" rowspan="1" colspan="1">Aichi Cancer Centre</td><td valign="top" align="left" rowspan="1" colspan="1">2000&#x02013;2004, 18&#x02013;79 years, men and women</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: 165, whereof <italic>ALDH2*1/*1</italic>: 38, <italic>ALDH2*1/*2</italic> and <italic>ALDH2*2/*2</italic>: 127<break/>Controls: 495</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: histologically diagnosed with primary cancer of the oesophagus (159 SCC, 6 adenocarcinomas)<break/>Controls: first-visit outpatients confirmed to be cancer-free (including no history of cancer assessed by questionnaire)</td><td valign="top" align="left" rowspan="1" colspan="1">Drinking levels: non-drinker, non-heavy drinkers (&#x0003c;&#x02009;5 drinking days/week and &#x0003c;&#x02009;50&#x000a0;g pure alcohol/occasion) and heavy drinkers (drinking &#x02265;&#x02009;5&#x000a0;days/week and &#x02265;&#x02009;50&#x000a0;g pure alcohol/occasion) were adjusted for in regression model as reported</td><td valign="top" align="left" rowspan="1" colspan="1">Age, sex, smoking, drinking</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Tanaka et al., 2010<xref rid="R38" ref-type="bibr"><sup>38</sup></xref><sup>a</sup></td><td valign="top" align="left" rowspan="1" colspan="1">Case-control</td><td valign="top" align="left" rowspan="1" colspan="1">Juntendo University Hospital, National Cancer Center Hospital, Kurume University Hospital, Saitama Cancer Center, Kagoshima University Hospital, Kyushu University Hospital</td><td valign="top" align="left" rowspan="1" colspan="1">2000&#x02013;2008, 35&#x02013;85 years, men and women</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: 742, whereof <italic>ALDH2*1/*1</italic>: 194, <italic>ALDH2*1/*2</italic> and <italic>ALDH2*2/*2</italic>: 548<break/>Controls: 820</td><td valign="top" align="left" rowspan="1" colspan="1">Cases: pathologically newly diagnosed SCC<break/>Controls: healthy controls without cancer history recruited from Kyushu University and Hospital and related hospitals</td><td valign="top" align="left" rowspan="1" colspan="1">Drinking levels: Non-drinker and ever drinkers</td><td valign="top" align="left" rowspan="1" colspan="1">Sex, age, study area</td></tr></tbody></table><table-wrap-foot><p>ADH1B: alcohol dehydrogenase 1B; ALDH2: aldehyde dehydrogenase 2; DSM: diagnostic statistical manual; ICD: International Classification of Diseases; JACC: Japan collaborative cohort study; JPHC: Japan public health centre-based prospective study; SCC: squamous cell carcinoma of the oesophagus.</p><p><sup>a</sup> Included in the sensitivity analysis on interaction between <italic>ALDH2</italic> and <italic>ADH1B</italic> on oesophageal cancer risk in Japan.</p><p>Note: <italic>ALDH2*2/*2</italic> was excluded in our analyses where possible because of the low number of cases.</p></table-wrap-foot></table-wrap><p>As shown in <xref ref-type="fig" rid="F2">Fig.&#x000a0;2</xref>, the risk for oesophageal cancer identified in cohort studies from Japan<xref rid="R39" ref-type="bibr"><sup>39</sup></xref><sup>&#x02013;</sup><xref rid="R41" ref-type="bibr"><sup>41</sup></xref> was higher compared with the most recent GBD estimate (RR:&#x02009;11.71; 95% confidence interval, CI: 2.67&#x02013;51.32 and RR:&#x02009;3.59; 95% CI: 3.34&#x02013;3.87, respectively at 100&#x000a0;g/day of pure alcohol intake). The risk identified in case-control studies<xref rid="R32" ref-type="bibr"><sup>32</sup></xref><sup>&#x02013;</sup><xref rid="R35" ref-type="bibr"><sup>35</sup></xref> (RR: 11.88; 95% CI: 4.41&#x02013;31.99 at 50&#x000a0;g/day of pure alcohol intake; RR: 33.11; 95% CI: 8.15&#x02013;134.43 at 100&#x000a0;g/day of pure alcohol intake) was much higher than the Japanese cohort studies or GBD estimates. In a meta-regression, the difference between case-control studies and cohort studies was significant (<italic>P</italic>&#x02009;=&#x02009;0.014). We observed moderate heterogeneity among cohort studies (<italic>I<sup>2</sup></italic>&#x02009;=&#x02009;60%, <italic>P</italic>&#x02009;=&#x02009;0.082), and high heterogeneity among case-control studies (<italic>I<sup>2</sup></italic>&#x02009;=&#x02009;89%, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001).</p><fig id="F2" fig-type="figure" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Risk curves for alcohol consumption and oesophageal cancer risk based on Japanese studies or the Global Burden of Disease 2010 study</p></caption><p>GBD: Global Burden of Disease; RR: relative risk.</p><graphic xlink:href="BLT.14.142141-F2"/></fig><p>The risk curves by <italic>ALDH2</italic> variants in Japan are displayed in <xref ref-type="fig" rid="F3">Fig.&#x000a0;3</xref>. Three case-control studies<xref rid="R33" ref-type="bibr"><sup>33</sup></xref><sup>,</sup><xref rid="R34" ref-type="bibr"><sup>34</sup></xref><sup>,</sup><xref rid="R36" ref-type="bibr"><sup>36</sup></xref> provided dose&#x02013;response data for an investigation of <italic>ALDH2</italic> polymorphisms in reference to non-drinkers: <italic>ALDH2*1/*2</italic> (372 cases) and <italic>ALDH2*1/*1</italic> (151 cases). Inactive variants of ALDH<italic>2</italic> enzyme showed markedly higher risks with increasing alcohol consumption. The RR compared to non-drinkers was 36.15 (95% CI: 10.34&#x02013;126.40) at 50&#x000a0;g/day of pure alcohol and 159 (95% CI: 27.2&#x02013;938.2) at 100&#x000a0;g/day of pure alcohol intake among people carrying the <italic>ALDH2*1/*2</italic> variant. In comparison, the RR among those carrying the <italic>ALDH2*1/*1</italic> variant was 2.99 (95% CI: 1.75&#x02013;5.12) at 50&#x000a0;g/day of pure alcohol intake and 8.94 (95% CI: 3.05&#x02013;26.23) at 100 g/day of pure alcohol. Based on two studies that included people with alcohol dependence (median 120&#x000a0;g/day of pure alcohol intake), people with the inactive variant of <italic>ALDH2</italic> had an RR of 13.00 (95% CI: 8.99&#x02013;18.80) compared to those with the active variant.<xref rid="R28" ref-type="bibr"><sup>28</sup></xref><sup>,</sup><xref rid="R29" ref-type="bibr"><sup>29</sup></xref> We interpolated this difference in risk in the curve for <italic>ALDH2*1/*2</italic> in <xref ref-type="fig" rid="F3">Fig.&#x000a0;3</xref>, and held the risk increase among people with this <italic>ALDH2</italic> variant constant beyond 100&#x000a0;g/day of pure alcohol intake because there were insufficient data to reliably estimate this risk function. Once case-control studies were stratified by <italic>ALDH2</italic> variant, there was little or no heterogeneity (<italic>ALDH2*1/*1</italic>, <italic>I<sup>2</sup></italic>&#x02009;=&#x02009;0%, <italic>P</italic>&#x02009;=&#x02009;0.78; <italic>ALDH2*1/*2</italic>, <italic>I<sup>2</sup></italic>&#x02009;=&#x02009;44%, <italic>P</italic>&#x02009;=&#x02009;0.17). Another two studies,<xref rid="R30" ref-type="bibr"><sup>30</sup></xref><sup>,</sup><xref rid="R31" ref-type="bibr"><sup>31</sup></xref> although they did not provide data in reference to non-drinkers, were in close agreement with our reported risk functions.</p><fig id="F3" fig-type="figure" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Risk curves for alcohol consumption and oesophageal cancer risk based on aldehyde dehydrogenase 2 polymorphisms, Japan</p></caption><p>ALDH2: aldehyde dehydrogenase 2; RR: relative risk.</p><p>Note: <italic>ALDH2*1/*1</italic> corresponds to an active enzyme and <italic>ALDH2*1/*2</italic> corresponds to an inactive enzyme.</p><graphic xlink:href="BLT.14.142141-F3"/></fig><p>With regard to differences in risk curves by study design, <xref ref-type="table" rid="T2">Table&#x000a0;2</xref> shows that among case-control studies with multiple alcohol intake categories, 72% (350/483) of oesophageal cancer cases among drinkers occurred in 32% (313/980) of the drinking population, namely individuals with the genetic variant <italic>ALDH2*1/*2</italic>. When the risk curves from case-control studies (<xref ref-type="fig" rid="F3">Fig.&#x000a0;3</xref>) were combined (weighted by their distribution of alcohol consumption by <italic>ALDH2</italic> variants at the population level) the risk functions from case-control and cohort studies almost entirely overlapped (<xref ref-type="fig" rid="F4">Fig.&#x000a0;4</xref>). Combining adjusted case-control and cohort studies, at 100 g/day pure alcohol intake, the risk in Japan was markedly elevated (RR: 11.65, 95% CI: 4.16&#x02013;32.62) compared to GBD estimates (RR: 3.55, 95% CI: 3.30&#x02013;3.82) (<xref ref-type="fig" rid="F5">Fig.&#x000a0;5</xref>).</p><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Distribution of alcohol consumption and the <italic>ALDH2</italic> polymorphism in individuals with oesophageal cancer and study controls, Japan</title></caption><table frame="hsides" rules="groups"><col width="95" span="1"/><col width="78" span="1"/><col width="72" span="1"/><col width="88" span="1"/><col width="68" span="1"/><col width="62" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Polymorphism</th><th colspan="5" valign="top" align="center" scope="colgroup" rowspan="1">Alcohol consumption, No<italic>.</italic> of individuals (%)<hr/></th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">Non-drinker</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">0&#x02013;25 g/day</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">&#x0003e;&#x02009;25&#x02013;75 g/day</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">&#x0003e;&#x02009;75 g/day</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Total</th></tr></thead><tbody><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Controls</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>ALDH2*1/*2</italic></td><td valign="top" align="center" rowspan="1" colspan="1">336 (52)</td><td valign="top" align="center" rowspan="1" colspan="1">234 (36)</td><td valign="top" align="center" rowspan="1" colspan="1">51 (8)</td><td valign="top" align="center" rowspan="1" colspan="1">28 (4)</td><td valign="top" align="center" rowspan="1" colspan="1">649 (100)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>ALDH2*1/*1</italic></td><td valign="top" align="center" rowspan="1" colspan="1">145 (18)</td><td valign="top" align="center" rowspan="1" colspan="1">350 (43)</td><td valign="top" align="center" rowspan="1" colspan="1">231 (28)</td><td valign="top" align="center" rowspan="1" colspan="1">86 (11)</td><td valign="top" align="center" rowspan="1" colspan="1">812 (100)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Oesophageal cancer cases</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>ALDH2*1/*2</italic></td><td valign="top" align="center" rowspan="1" colspan="1">22 (6)</td><td valign="top" align="center" rowspan="1" colspan="1">94 (25)</td><td valign="top" align="center" rowspan="1" colspan="1">180 (48)</td><td valign="top" align="center" rowspan="1" colspan="1">76 (20)</td><td valign="top" align="center" rowspan="1" colspan="1">372 (100)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>ALDH2*1/*1</italic></td><td valign="top" align="center" rowspan="1" colspan="1">18 (12)</td><td valign="top" align="center" rowspan="1" colspan="1">35 (23)</td><td valign="top" align="center" rowspan="1" colspan="1">61 (40)</td><td valign="top" align="center" rowspan="1" colspan="1">37 (25)</td><td valign="top" align="center" rowspan="1" colspan="1">151 (100)</td></tr></tbody></table><table-wrap-foot><p>ALDH2: aldehyde dehydrogenase 2.</p><p>Note: The <italic>ALDH2*1/*1</italic> corresponds to an active enzyme and <italic>ALDH2*1/*2</italic> corresponds to an inactive enzyme.</p><p>Data sources: Yokoyama et al.<xref rid="R36" ref-type="bibr"><sup>36</sup></xref> Yokoyama et al.<xref rid="R33" ref-type="bibr"><sup>33</sup></xref> Oze et al.<xref rid="R34" ref-type="bibr"><sup>34</sup></xref></p></table-wrap-foot></table-wrap><fig id="F4" fig-type="figure" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Risk curves for alcohol consumption and oesophageal cancer risk adjusted for aldehyde dehydrogenase 2 polymorphisms, Japan</p></caption><p>ALDH2: aldehyde dehydrogenase 2; RR: relative risk.</p><p>Notes: <italic>ALDH2*1/*1</italic> corresponds to an active enzyme and <italic>ALDH2*1/*2</italic> corresponds to an inactive enzyme. The relative risk curves by study design overlap almost completely after adjustment for drinking levels at the population level by ALDH2 variants.</p><graphic xlink:href="BLT.14.142141-F4"/></fig><fig id="F5" fig-type="figure" orientation="portrait" position="float"><label>Fig. 5</label><caption><p>Risk curves for alcohol consumption and oesophageal cancer risk based on Japanese studies adjusted for aldehyde dehydrogenase 2 polymorphisms and the Global Burden of Disease 2010 study</p></caption><p>ALDH2: aldehyde dehydrogenase 2; RR: relative risk.</p><graphic xlink:href="BLT.14.142141-F5"/></fig><p>To investigate the interaction between <italic>ALDH2</italic> and <italic>ADH1B</italic> gene variants, we performed a sensitivity analysis using five of the 11 identified case-control studies.<xref rid="R29" ref-type="bibr"><sup>29</sup></xref><sup>,</sup><xref rid="R31" ref-type="bibr"><sup>31</sup></xref><sup>,</sup><xref rid="R36" ref-type="bibr"><sup>36</sup></xref><sup>&#x02013;</sup><xref rid="R38" ref-type="bibr"><sup>38</sup></xref> Regardless of <italic>ALDH2</italic> variant, the pooled RRs were higher for Japanese with the slow-acting <italic>ADH1B*1/*1</italic> variant than for Japanese with the fast-acting <italic>ADH1B*1/*2</italic> or <italic>*2/*2</italic> variants. The RR was 3.99 (95% CI: 2.41&#x02013;6.61; I<sup>2</sup>&#x02009;=&#x02009;81%, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) and 2.40 (95% CI: 1.92&#x02013;3.16; I<sup>2</sup>&#x02009;=&#x02009;1%, <italic>P</italic>&#x02009;=&#x02009;0.40) for individuals with an inactive and active ALDH2, respectively (<xref ref-type="fig" rid="F6">Fig.&#x000a0;6</xref> and <xref ref-type="fig" rid="F7">Fig.&#x000a0;7</xref>). </p><fig id="F6" fig-type="figure" orientation="portrait" position="float"><label>Fig. 6</label><caption><p>Relationship between alcohol dehydrogenase 1B polymorphisms and oesophageal cancer risk in Japanese with inactive aldehyde dehydrogenase 2</p></caption><p>ADH1B: alcohol dehydrogenase 1B; CI: confidence interval; RR: relative risk.</p><graphic xlink:href="BLT.14.142141-F6"/></fig><fig id="F7" fig-type="figure" orientation="portrait" position="float"><label>Fig. 7</label><caption><p>Relationship between alcohol dehydrogenase 1B polymorphisms and oesophageal cancer risk in Japanese people with active aldehyde dehydrogenase 2</p></caption><p>ADH1B: alcohol dehydrogenase 1B; CI: confidence interval; RR: relative risk.</p><p>Note: <italic>ADH1B*1/*1</italic> corresponds to the slow-acting form of the enzyme and <italic>ADH1B*1/*2 and ADH1B*2/*2</italic> corresponds to the fast-acting form.</p><graphic xlink:href="BLT.14.142141-F7"/></fig><p>Using our calculated risk relations for alcohol-attributable oesophageal cancer results in almost twofold higher estimates for deaths (5279) and DALYs lost (102&#x02009;988) compared with the current GBD estimates (2749 and 53&#x02009;826, respectively; <xref ref-type="table" rid="T3">Table&#x000a0;3</xref>). These results are irrespective of whether the estimates were based on cohort studies or on case-control studies, in each case adjusted for population prevalence of genotypes.</p><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><title>Estimated mortality and burden of disease for alcohol-attributable oesophageal cancer in Japan 2010</title></caption><table frame="hsides" rules="groups"><col width="195" span="1"/><col width="60" span="1"/><col width="78" span="1"/><col width="14" span="1"/><col width="56" span="1"/><col width="77" span="1"/><col width="14" span="1"/><col width="56" span="1"/><col width="77" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Estimate</th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">Women<hr/></th><th rowspan="2" valign="top" align="left" scope="col" colspan="1"/><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">Men<hr/></th><th rowspan="2" valign="top" align="left" scope="col" colspan="1"/><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">Total<hr/></th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">No. of deaths</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">No. of DALYs</th><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">No. of deaths</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">No. of DALYs</th><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">No. of deaths</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">No. of DALYs</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">GBD 2010</td><td valign="top" align="center" rowspan="1" colspan="1">202</td><td valign="top" align="center" rowspan="1" colspan="1">3&#x000a0;089</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">2&#x000a0;547</td><td valign="top" align="center" rowspan="1" colspan="1">50&#x02009;737</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">2&#x000a0;749</td><td valign="top" align="center" rowspan="1" colspan="1">53&#x02009;826</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Japanese cohort studies</td><td valign="top" align="center" rowspan="1" colspan="1">346</td><td valign="top" align="center" rowspan="1" colspan="1">5&#x000a0;498</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">4&#x000a0;925</td><td valign="top" align="center" rowspan="1" colspan="1">97&#x02009;284</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">5&#x000a0;271</td><td valign="top" align="center" rowspan="1" colspan="1">102&#x02009;782</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Japanese adjusted case-control studies</td><td valign="top" align="center" rowspan="1" colspan="1">346</td><td valign="top" align="center" rowspan="1" colspan="1">5&#x000a0;514</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">4&#x000a0;933</td><td valign="top" align="center" rowspan="1" colspan="1">97&#x02009;474</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">5&#x000a0;279</td><td valign="top" align="center" rowspan="1" colspan="1">102&#x02009;988</td></tr></tbody></table><table-wrap-foot><p>DALYs: disability-adjusted life-years; GBD: Global Burden of Disease.</p></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>Discussion</title><p>For Japan, we estimated a twofold higher mortality and burden of disease using risk functions derived from Japanese populations compared with the 2010 GBD estimates, which are based on global risk functions. We obtained separate estimates based on independent methods &#x02013; either Japanese cohort data or adjusted Japanese case-control studies &#x02013; and these estimates were comparable. This strengthens our conclusion that the current GBD method underestimates Japanese oesophageal cancer outcomes. Since we took into consideration genetic polymorphisms commonly observed in the Japanese population, we would predict a similar degree of underestimation for alcohol-attributable oral, pharynx and larynx cancers in Japan.<xref rid="R34" ref-type="bibr"><sup>34</sup></xref><sup>,</sup><xref rid="R42" ref-type="bibr"><sup>42</sup></xref><sup>,</sup><xref rid="R43" ref-type="bibr"><sup>43</sup></xref> Furthermore, the burden of other alcohol-attributable cancers where acetaldehyde plays an important role might be underestimated.<xref rid="R3" ref-type="bibr"><sup>3</sup></xref><sup>,</sup><xref rid="R4" ref-type="bibr"><sup>4</sup></xref></p><p>We found that the slow-acting <italic>ADH1B</italic> variant also increased the risk for oesophageal cancer, regardless of <italic>ALDH2</italic> variant. However, the slow-acting variant is only present in 6% of the Japanese population,<xref rid="R44" ref-type="bibr"><sup>44</sup></xref> whereas 90% of Caucasians carry the variant.<xref rid="R45" ref-type="bibr"><sup>45</sup></xref> As we had restricted all our analyses to Japanese individuals, the potential protective effect of the fast-acting <italic>ADH1B*1/*2</italic> or <italic>*2/*2</italic> variants has been already included. Similarly, risk estimates from cohort studies should not be affected by the differential risk curves for <italic>ALDH2</italic> and <italic>ADH1B</italic> variants and their combinations if the prevalence of each combination of polymorphisms is reflected in the sample.</p><p>The study has some limitations. First, any systematic review or meta-analysis is only as good as the literature it is based on. Although case-control studies initially showed high heterogeneity as measured by <italic>I<sup>2</sup></italic> values indicating potential bias, there was little heterogeneity after these studies were stratified by <italic>ALDH2</italic> variants. Second, while the procedures to estimate alcohol-attributable fractions are standard,<xref rid="R26" ref-type="bibr"><sup>26</sup></xref><sup>,</sup><xref rid="R27" ref-type="bibr"><sup>27</sup></xref><sup>,</sup><xref rid="R46" ref-type="bibr"><sup>46</sup></xref> subsequent adjustments to survey results may bias consumption in either direction.<xref rid="R47" ref-type="bibr"><sup>47</sup></xref><sup>&#x02013;</sup><xref rid="R49" ref-type="bibr"><sup>49</sup></xref> However, as the same method of triangulation of surveys and per capita estimation was applied to GBD and to national estimates,<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> the comparison between these estimates should be valid. Finally, the estimates of attributable risk and burden of disease for heavy alcohol intake are based on few studies and thus may be biased.<xref rid="R50" ref-type="bibr"><sup>50</sup></xref> By including risk estimates of people with alcohol dependence, we attempted to minimize this bias.</p><p>While there may be some biases in our quantitative estimates of alcohol-attributable burden for oesophageal cancer, they still show that global estimates underestimate the burden in Japan. This will likely be true for GBD estimates for China and the Republic of Korea as well, where a considerable proportion of the population also carry the inactive <italic>ALDH2</italic> allele, (34% and 29%, respectively).<xref rid="R44" ref-type="bibr"><sup>44</sup></xref> In populations with a high proportion of these polymorphisms, studies based on global dose response data are likely to underestimate many alcohol-attributable cancers.</p><p>Efforts should be made to estimate country-specific risks for diseases affected by genetic polymorphisms, especially in countries with higher proportions of such polymorphisms. The current standard of applying global risk functions to local exposure data should be replaced by country-specific risk functions whenever possible. Country-specific risk functions should also be applied for other risk factors than alcohol.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="R51" ref-type="bibr"><sup>51</sup></xref> This will allow for better estimation of the burdens caused by risk factors and consequently better informed policy measures.</p></sec></body><back><fn-group><title>Competing interests:</title><fn fn-type="financial-disclosure"><p>SH has received grants from Lundbeck Japan during the conduct of the study; grants from the Japanese government, Lundbeck Japan, Suntory, grants and personal fees from Nippon Shinyaku, outside the submitted work. JR has received an unrestricted grant from Lundbeck pharmaceuticals for the study. The other authors declare no competing interests.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><mixed-citation publication-type="journal"><string-name><surname>Lim</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Vos</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Flaxman</surname>
<given-names>AD</given-names></string-name>, <string-name><surname>Danaei</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Shibuya</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Adair-Rohani</surname>
<given-names>H</given-names></string-name>, <etal>et al.</etal>
<article-title>A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990&#x02013;2010: a systematic analysis for the GBD Study 2010.</article-title>
<source>Lancet</source>. <year>2012</year>
<month>12</month>
<day>15</day>;<volume>380</volume>(<issue>9859</issue>):<fpage>2224</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(12)61766-8</pub-id><pub-id pub-id-type="pmid">23245609</pub-id></mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="journal"><string-name><surname>Rehm</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Mathers</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Popova</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Thavorncharoensap</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Teerawattananon</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Patra</surname>
<given-names>J</given-names></string-name>. <article-title>GBD and injury and economic cost attributable to alcohol use and alcohol-use disorders.</article-title>
<source>Lancet</source>. <year>2009</year>
<month>6</month>
<day>27</day>;<volume>373</volume>(<issue>9682</issue>):<fpage>2223</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(09)60746-7</pub-id><pub-id pub-id-type="pmid">19560604</pub-id></mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="book"><source>Alcohol consumption and ethyl carbamate. Monograph 96 on the evaluation of carcinogenic risks to humans.</source>
<publisher-loc>Lyon</publisher-loc>: <publisher-name>International Agency for Research on Cancer</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="book"><source>Personal habits and indoor combustions.</source>
<publisher-loc>Lyon</publisher-loc>: <publisher-name>International Agency for Research on Cancer</publisher-name>; <year>2012</year>.</mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="journal"><string-name><surname>Rehm</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Shield</surname>
<given-names>KD</given-names></string-name>. <article-title>Global alcohol-attributable deaths from cancer, liver cirrhosis, and injury in 2010.</article-title>
<source>Alcohol Res</source>. <year>2013</year>;<volume>35</volume>(<issue>2</issue>):<fpage>174</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="pmid">24881325</pub-id></mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="book"><string-name><surname>Rehm</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Shield</surname>
<given-names>K</given-names></string-name>. <chapter-title>Alcohol consumption.</chapter-title> In: <string-name><surname>Steward</surname>
<given-names>BW</given-names></string-name>, <string-name><surname>Wild</surname>
<given-names>CP</given-names></string-name>, editors. <source>World cancer report.</source>
<publisher-loc>Lyon</publisher-loc>: <publisher-name>International Agency for Research on Cancer</publisher-name>; <year>2014</year> pp. <fpage>97</fpage>&#x02013;<lpage>107</lpage>.</mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="journal"><string-name><surname>Murray</surname>
<given-names>CJL</given-names></string-name>, <string-name><surname>Lopez</surname>
<given-names>AD</given-names></string-name>. <article-title>On the comparable quantification of health risks: lessons from the GBD Study.</article-title>
<source>Epidemiology</source>. <year>1999</year>
<month>9</month>;<volume>10</volume>(<issue>5</issue>):<fpage>594</fpage>&#x02013;<lpage>605</lpage>. <pub-id pub-id-type="doi">10.1097/00001648-199909000-00029</pub-id><pub-id pub-id-type="pmid">10468439</pub-id></mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="book"><string-name><surname>Stewart</surname>
<given-names>BW</given-names></string-name>, <string-name><surname>Wild</surname>
<given-names>CP</given-names></string-name>, editors. <source>World cancer report 2014.</source>
<publisher-loc>Lyon</publisher-loc>: <publisher-name>International Agency for Research on Cancer</publisher-name>; <year>2014</year>.</mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="web">GBD compare [Internet]. Seattle: Institute for Health Metrics and Evaluation; 2013. Available from: <ext-link ext-link-type="uri" xlink:href="http://vizhub.healthdata.org/gbd-compare/">http://vizhub.healthdata.org/gbd-compare/</ext-link> [cited 2015 Feb 9].</mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal"><string-name><surname>Rehm</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Baliunas</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Borges</surname>
<given-names>GLG</given-names></string-name>, <string-name><surname>Graham</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Irving</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Kehoe</surname>
<given-names>T</given-names></string-name>, <etal>et al.</etal>
<article-title>The relation between different dimensions of alcohol consumption and burden of disease: an overview.</article-title>
<source>Addiction</source>. <year>2010</year>
<month>5</month>;<volume>105</volume>(<issue>5</issue>):<fpage>817</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1111/j.1360-0443.2010.02899.x</pub-id><pub-id pub-id-type="pmid">20331573</pub-id></mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="journal"><string-name><surname>Corrao</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Bagnardi</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Zambon</surname>
<given-names>A</given-names></string-name>, <string-name><surname>La Vecchia</surname>
<given-names>C</given-names></string-name>. <article-title>A meta-analysis of alcohol consumption and the risk of 15 diseases.</article-title>
<source>Prev Med</source>. <year>2004</year>
<month>5</month>;<volume>38</volume>(<issue>5</issue>):<fpage>613</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.ypmed.2003.11.027</pub-id><pub-id pub-id-type="pmid">15066364</pub-id></mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="journal"><string-name><surname>Brooks</surname>
<given-names>PJ</given-names></string-name>, <string-name><surname>Enoch</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Goldman</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>TK</given-names></string-name>, <string-name><surname>Yokoyama</surname>
<given-names>A</given-names></string-name>. <article-title>The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption.</article-title>
<source>PLoS Med</source>. <year>2009</year>
<month>3</month>
<day>24</day>;<volume>6</volume>(<issue>3</issue>):<fpage>e50</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1000050</pub-id><pub-id pub-id-type="pmid">19320537</pub-id></mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="journal"><string-name><surname>Yang</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Yokoyama</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Yokoyama</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>YC</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>SY</given-names></string-name>, <string-name><surname>Shao</surname>
<given-names>Y</given-names></string-name>, <etal>et al.</etal>
<article-title>Relationship between genetic polymorphisms of ALDH2 and ADH1B and esophageal cancer risk: a meta-analysis.</article-title>
<source>World J Gastroenterol</source>. <year>2010</year>
<month>9</month>
<day>7</day>;<volume>16</volume>(<issue>33</issue>):<fpage>4210</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v16.i33.4210</pub-id><pub-id pub-id-type="pmid">20806441</pub-id></mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="journal"><string-name><surname>Fang</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Jiao</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Gao</surname>
<given-names>Y</given-names></string-name>, <etal>et al.</etal>
<article-title>Meta-analysis of ALDH2 variants and esophageal cancer in Asians.</article-title>
<source>Asian Pac J Cancer Prev</source>. <year>2011</year>;<volume>12</volume>(<issue>10</issue>):<fpage>2623</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">22320964</pub-id></mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="journal"><string-name><surname>Hiyama</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Yoshihara</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Tanaka</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Chayama</surname>
<given-names>K</given-names></string-name>. <article-title>Genetic polymorphisms and esophageal cancer risk.</article-title>
<source>Int J Cancer</source>. <year>2007</year>
<month>10</month>
<day>15</day>;<volume>121</volume>(<issue>8</issue>):<fpage>1643</fpage>&#x02013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.23044</pub-id><pub-id pub-id-type="pmid">17674367</pub-id></mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="journal"><string-name><surname>Moher</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Liberati</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Tetzlaff</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Altman</surname>
<given-names>DG</given-names></string-name>; <collab>PRISMA Group</collab>. <article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.</article-title>
<source>PLoS Med</source>. <year>2009</year>
<month>7</month>
<day>21</day>;<volume>6</volume>(<issue>7</issue>):<fpage>e1000097</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1000097</pub-id><pub-id pub-id-type="pmid">19621072</pub-id></mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="journal"><string-name><surname>Moher</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Pham</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Jones</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Cook</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Jadad</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Moher</surname>
<given-names>M</given-names></string-name>, <etal>et al.</etal>
<article-title>Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?</article-title>
<source>Lancet</source>. <year>1998</year>
<month>8</month>
<day>22</day>;<volume>352</volume>(<issue>9128</issue>):<fpage>609</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(98)01085-X</pub-id><pub-id pub-id-type="pmid">9746022</pub-id></mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="journal"><string-name><surname>Detsky</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Naylor</surname>
<given-names>CD</given-names></string-name>, <string-name><surname>O&#x02019;Rourke</surname>
<given-names>K</given-names></string-name>, <string-name><surname>McGeer</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>L&#x02019;Abb&#x000e9;</surname>
<given-names>KA</given-names></string-name>. <article-title>Incorporating variations in the quality of individual randomized trials into meta-analysis.</article-title>
<source>J Clin Epidemiol</source>. <year>1992</year>
<month>3</month>;<volume>45</volume>(<issue>3</issue>):<fpage>255</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/0895-4356(92)90085-2</pub-id><pub-id pub-id-type="pmid">1569422</pub-id></mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="journal"><string-name><surname>Greenland</surname>
<given-names>S</given-names></string-name>, <string-name><surname>O&#x02019;Rourke</surname>
<given-names>K</given-names></string-name>. <article-title>On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions.</article-title>
<source>Biostatistics</source>. <year>2001</year>
<month>12</month>;<volume>2</volume>(<issue>4</issue>):<fpage>463</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1093/biostatistics/2.4.463</pub-id><pub-id pub-id-type="pmid">12933636</pub-id></mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="journal"><string-name><surname>Herbison</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Hay-Smith</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Gillespie</surname>
<given-names>WJ</given-names></string-name>. <article-title>Adjustment of meta-analyses on the basis of quality scores should be abandoned.</article-title>
<source>J Clin Epidemiol</source>. <year>2006</year>
<month>12</month>;<volume>59</volume>(<issue>12</issue>):<fpage>1249</fpage>&#x02013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.jclinepi.2006.03.008</pub-id><pub-id pub-id-type="pmid">17098567</pub-id></mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="book"><string-name><surname>Royston</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Sauerbrei</surname>
<given-names>W</given-names></string-name>. <source>Multivariable model-building: a pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables.</source>
<publisher-loc>Hoboken</publisher-loc>: <publisher-name>John Wiley &#x00026; Sons</publisher-name>; <year>2008</year>
<pub-id pub-id-type="doi">10.1002/9780470770771</pub-id></mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="journal"><string-name><surname>Orsini</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Bellocco</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Greenland</surname>
<given-names>S</given-names></string-name>. <article-title>Generalized least squares for trend estimation of summarized dose-response data.</article-title>
<source>Stata J</source>. <year>2006</year>;<volume>6</volume>(<issue>1</issue>):<fpage>40</fpage>&#x02013;<lpage>57</lpage>.</mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="journal"><string-name><surname>DerSimonian</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Laird</surname>
<given-names>N</given-names></string-name>. <article-title>Meta-analysis in clinical trials.</article-title>
<source>Control Clin Trials</source>. <year>1986</year>
<month>9</month>;<volume>7</volume>(<issue>3</issue>):<fpage>177</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/0197-2456(86)90046-2</pub-id><pub-id pub-id-type="pmid">3802833</pub-id></mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="journal"><string-name><surname>Higgins</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Thompson</surname>
<given-names>SG</given-names></string-name>. <article-title>Quantifying heterogeneity in a meta-analysis.</article-title>
<source>Stat Med</source>. <year>2002</year>
<month>6</month>
<day>15</day>;<volume>21</volume>(<issue>11</issue>):<fpage>1539</fpage>&#x02013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1002/sim.1186</pub-id><pub-id pub-id-type="pmid">12111919</pub-id></mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="journal"><string-name><surname>Egger</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Davey Smith</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Schneider</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Minder</surname>
<given-names>C</given-names></string-name>. <article-title>Bias in meta-analysis detected by a simple, graphical test.</article-title>
<source>BMJ</source>. <year>1997</year>
<month>9</month>
<day>13</day>;<volume>315</volume>(<issue>7109</issue>):<fpage>629</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1136/bmj.315.7109.629</pub-id><pub-id pub-id-type="pmid">9310563</pub-id></mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="journal"><string-name><surname>Kehoe</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Gmel</surname>
<given-names>G</given-names>
<suffix>Jr</suffix></string-name>, <string-name><surname>Shield</surname>
<given-names>KD</given-names></string-name>, <string-name><surname>Gmel</surname>
<given-names>G</given-names>
<suffix>Sr</suffix></string-name>, <string-name><surname>Rehm</surname>
<given-names>J</given-names></string-name>. <article-title>Determining the best population-level alcohol consumption model and its impact on estimates of alcohol-attributable harms.</article-title>
<source>Popul Health Metr</source>. <year>2012</year>;<volume>10</volume>(<issue>1</issue>):<fpage>6</fpage>. <pub-id pub-id-type="doi">10.1186/1478-7954-10-6</pub-id><pub-id pub-id-type="pmid">22490226</pub-id></mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="journal"><string-name><surname>Shield</surname>
<given-names>KD</given-names></string-name>, <string-name><surname>Rylett</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gmel</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Gmel</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Kehoe-Chan</surname>
<given-names>TA</given-names></string-name>, <string-name><surname>Rehm</surname>
<given-names>J</given-names></string-name>. <article-title>Global alcohol exposure estimates by country, territory and region for 2005&#x02013;a contribution to the comparative risk assessment for the 2010 GBD Study.</article-title>
<source>Addiction</source>. <year>2013</year>
<month>5</month>;<volume>108</volume>(<issue>5</issue>):<fpage>912</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1111/add.12112</pub-id><pub-id pub-id-type="pmid">23347092</pub-id></mixed-citation></ref><ref id="R28"><label>28</label><mixed-citation publication-type="journal"><string-name><surname>Yokoyama</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Muramatsu</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Ohmori</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Yokoyama</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Okuyama</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Takahashi</surname>
<given-names>H</given-names></string-name>, <etal>et al.</etal>
<article-title>Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics.</article-title>
<source>Carcinogenesis</source>. <year>1998</year>
<month>8</month>;<volume>19</volume>(<issue>8</issue>):<fpage>1383</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1093/carcin/19.8.1383</pub-id><pub-id pub-id-type="pmid">9744533</pub-id></mixed-citation></ref><ref id="R29"><label>29</label><mixed-citation publication-type="journal"><string-name><surname>Yokoyama</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Muramatsu</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Omori</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Yokoyama</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Matsushita</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Higuchi</surname>
<given-names>S</given-names></string-name>, <etal>et al.</etal>
<article-title>Alcohol and aldehyde dehydrogenase gene polymorphisms and oropharyngolaryngeal, esophageal and stomach cancers in Japanese alcoholics.</article-title>
<source>Carcinogenesis</source>. <year>2001</year>
<month>3</month>;<volume>22</volume>(<issue>3</issue>):<fpage>433</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/carcin/22.3.433</pub-id><pub-id pub-id-type="pmid">11238183</pub-id></mixed-citation></ref><ref id="R30"><label>30</label><mixed-citation publication-type="journal"><string-name><surname>Matsuo</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Hamajima</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Shinoda</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Hatooka</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Inoue</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Takezaki</surname>
<given-names>T</given-names></string-name>, <etal>et al.</etal>
<article-title>Gene-environment interaction between an aldehyde dehydrogenase-2 (ALDH2) polymorphism and alcohol consumption for the risk of esophageal cancer.</article-title>
<source>Carcinogenesis</source>. <year>2001</year>
<month>6</month>;<volume>22</volume>(<issue>6</issue>):<fpage>913</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1093/carcin/22.6.913</pub-id><pub-id pub-id-type="pmid">11375898</pub-id></mixed-citation></ref><ref id="R31"><label>31</label><mixed-citation publication-type="journal"><string-name><surname>Cui</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Kamatani</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Takahashi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Usami</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Hosono</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Kawaguchi</surname>
<given-names>T</given-names></string-name>, <etal>et al.</etal>
<article-title>Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk.</article-title>
<source>Gastroenterology</source>. <year>2009</year>
<month>11</month>;<volume>137</volume>(<issue>5</issue>):<fpage>1768</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2009.07.070</pub-id><pub-id pub-id-type="pmid">19698717</pub-id></mixed-citation></ref><ref id="R32"><label>32</label><mixed-citation publication-type="journal"><string-name><surname>Yokoyama</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Yokoyama</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kato</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Tsujinaka</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Muto</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Omori</surname>
<given-names>T</given-names></string-name>, <etal>et al.</etal>
<article-title>Alcohol flushing, alcohol and aldehyde dehydrogenase genotypes, and risk for esophageal squamous cell carcinoma in Japanese men.</article-title>
<source>Cancer Epidemiol Biomarkers Prev</source>. <year>2003</year>
<month>11</month>;<volume>12</volume>(<issue>11 Pt 1</issue>):<fpage>1227</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="pmid">14652286</pub-id></mixed-citation></ref><ref id="R33"><label>33</label><mixed-citation publication-type="journal"><string-name><surname>Yokoyama</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kato</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Yokoyama</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Igaki</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Tsujinaka</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Muto</surname>
<given-names>M</given-names></string-name>, <etal>et al.</etal>
<article-title>Esophageal squamous cell carcinoma and aldehyde dehydrogenase-2 genotypes in Japanese females.</article-title>
<source>Alcohol Clin Exp Res</source>. <year>2006</year>
<month>3</month>;<volume>30</volume>(<issue>3</issue>):<fpage>491</fpage>&#x02013;<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1111/j.1530-0277.2006.00053.x</pub-id><pub-id pub-id-type="pmid">16499490</pub-id></mixed-citation></ref><ref id="R34"><label>34</label><mixed-citation publication-type="journal"><string-name><surname>Oze</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Matsuo</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Hosono</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ito</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Kawase</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Watanabe</surname>
<given-names>M</given-names></string-name>, <etal>et al.</etal>
<article-title>Comparison between self-reported facial flushing after alcohol consumption and ALDH2 Glu504Lys polymorphism for risk of upper aerodigestive tract cancer in a Japanese population.</article-title>
<source>Cancer Sci</source>. <year>2010</year>
<month>8</month>;<volume>101</volume>(<issue>8</issue>):<fpage>1875</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1111/j.1349-7006.2010.01599.x</pub-id><pub-id pub-id-type="pmid">20518787</pub-id></mixed-citation></ref><ref id="R35"><label>35</label><mixed-citation publication-type="journal"><string-name><surname>Takezaki</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Shinoda</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Hatooka</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hasegawa</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Nakamura</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hirose</surname>
<given-names>K</given-names></string-name>, <etal>et al.</etal>
<article-title>Subsite-specific risk factors for hypopharyngeal and esophageal cancer (Japan).</article-title>
<source>Cancer Causes Control</source>. <year>2000</year>
<month>8</month>;<volume>11</volume>(<issue>7</issue>):<fpage>597</fpage>&#x02013;<lpage>608</lpage>. <pub-id pub-id-type="doi">10.1023/A:1008909129756</pub-id><pub-id pub-id-type="pmid">10977104</pub-id></mixed-citation></ref><ref id="R36"><label>36</label><mixed-citation publication-type="journal"><string-name><surname>Yokoyama</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kato</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Yokoyama</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Tsujinaka</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Muto</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Omori</surname>
<given-names>T</given-names></string-name>, <etal>et al.</etal>
<article-title>Genetic polymorphisms of alcohol and aldehyde dehydrogenases and glutathione S-transferase M1 and drinking, smoking, and diet in Japanese men with esophageal squamous cell carcinoma.</article-title>
<source>Carcinogenesis</source>. <year>2002</year>
<month>11</month>;<volume>23</volume>(<issue>11</issue>):<fpage>1851</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/carcin/23.11.1851</pub-id><pub-id pub-id-type="pmid">12419833</pub-id></mixed-citation></ref><ref id="R37"><label>37</label><mixed-citation publication-type="journal"><string-name><surname>Yang</surname>
<given-names>CX</given-names></string-name>, <string-name><surname>Matsuo</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Ito</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Hirose</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Wakai</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Saito</surname>
<given-names>T</given-names></string-name>, <etal>et al.</etal>
<article-title>Esophageal cancer risk by ALDH2 and ADH2 polymorphisms and alcohol consumption: exploration of gene-environment and gene-gene interactions.</article-title>
<source>Asian Pac J Cancer Prev</source>. <year>2005</year>
<season>Jul-Sep</season>;<volume>6</volume>(<issue>3</issue>):<fpage>256</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="pmid">16235983</pub-id></mixed-citation></ref><ref id="R38"><label>38</label><mixed-citation publication-type="journal"><string-name><surname>Tanaka</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Yamamoto</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Suzuki</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Inoue</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Tsurumaru</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kajiyama</surname>
<given-names>Y</given-names></string-name>, <etal>et al.</etal>
<article-title>Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk alleles.</article-title>
<source>Gut</source>. <year>2010</year>
<month>11</month>;<volume>59</volume>(<issue>11</issue>):<fpage>1457</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1136/gut.2009.205724</pub-id><pub-id pub-id-type="pmid">20833657</pub-id></mixed-citation></ref><ref id="R39"><label>39</label><mixed-citation publication-type="journal"><string-name><surname>Ishiguro</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Sasazuki</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Inoue</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kurahashi</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Iwasaki</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Tsugane</surname>
<given-names>S</given-names></string-name>; <collab>JPHC Study Group</collab>. <article-title>Effect of alcohol consumption, cigarette smoking and flushing response on esophageal cancer risk: a population-based cohort study (JPHC study).</article-title>
<source>Cancer Lett</source>. <year>2009</year>
<month>3</month>
<day>18</day>;<volume>275</volume>(<issue>2</issue>):<fpage>240</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2008.10.020</pub-id><pub-id pub-id-type="pmid">19036500</pub-id></mixed-citation></ref><ref id="R40"><label>40</label><mixed-citation publication-type="journal"><string-name><surname>Nakaya</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Tsubono</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Kuriyama</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hozawa</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Shimazu</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Kurashima</surname>
<given-names>K</given-names></string-name>, <etal>et al.</etal>
<article-title>Alcohol consumption and the risk of cancer in Japanese men: the Miyagi cohort study.</article-title>
<source>Eur J Cancer Prev</source>. <year>2005</year>
<month>4</month>;<volume>14</volume>(<issue>2</issue>):<fpage>169</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1097/00008469-200504000-00013</pub-id><pub-id pub-id-type="pmid">15785321</pub-id></mixed-citation></ref><ref id="R41"><label>41</label><mixed-citation publication-type="journal"><string-name><surname>Ozasa</surname>
<given-names>K</given-names></string-name>; <collab>Japan Collaborative Cohort Study for Evaluation of Cancer</collab>. <article-title>Alcohol use and mortality in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC).</article-title>
<source>Asian Pac J Cancer Prev</source>. <year>2007</year>;<volume>8</volume>
<issue>Suppl</issue>:<fpage>81</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">18260706</pub-id></mixed-citation></ref><ref id="R42"><label>42</label><mixed-citation publication-type="journal"><string-name><surname>Boccia</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hashibe</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gall&#x000ec;</surname>
<given-names>P</given-names></string-name>, <string-name><surname>De Feo</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Asakage</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Hashimoto</surname>
<given-names>T</given-names></string-name>, <etal>et al.</etal>
<article-title>Aldehyde dehydrogenase 2 and head and neck cancer: a meta-analysis implementing a Mendelian randomization approach.</article-title>
<source>Cancer Epidemiol Biomarkers Prev</source>. <year>2009</year>
<month>1</month>;<volume>18</volume>(<issue>1</issue>):<fpage>248</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1158/1055-9965.EPI-08-0462</pub-id><pub-id pub-id-type="pmid">19124505</pub-id></mixed-citation></ref><ref id="R43"><label>43</label><mixed-citation publication-type="journal"><string-name><surname>Yokoyama</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Omori</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Yokoyama</surname>
<given-names>T</given-names></string-name>. <article-title>Alcohol and aldehyde dehydrogenase polymorphisms and a new strategy for prevention and screening for cancer in the upper aerodigestive tract in East Asians.</article-title>
<source>Keio J Med</source>. <year>2010</year>;<volume>59</volume>(<issue>4</issue>):<fpage>115</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.2302/kjm.59.115</pub-id><pub-id pub-id-type="pmid">21187698</pub-id></mixed-citation></ref><ref id="R44"><label>44</label><mixed-citation publication-type="journal"><string-name><surname>Eng</surname>
<given-names>MY</given-names></string-name>, <string-name><surname>Luczak</surname>
<given-names>SE</given-names></string-name>, <string-name><surname>Wall</surname>
<given-names>TL</given-names></string-name>. <article-title>ALDH2, ADH1B, and ADH1C genotypes in Asians: a literature review.</article-title>
<source>Alcohol Res Health</source>. <year>2007</year>;<volume>30</volume>(<issue>1</issue>):<fpage>22</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">17718397</pub-id></mixed-citation></ref><ref id="R45"><label>45</label><mixed-citation publication-type="journal"><string-name><surname>Goedde</surname>
<given-names>HW</given-names></string-name>, <string-name><surname>Agarwal</surname>
<given-names>DP</given-names></string-name>, <string-name><surname>Fritze</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Meier-Tackmann</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Singh</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Beckmann</surname>
<given-names>G</given-names></string-name>, <etal>et al.</etal>
<article-title>Distribution of ADH2 and ALDH2 genotypes in different populations.</article-title>
<source>Hum Genet</source>. <year>1992</year>
<month>1</month>;<volume>88</volume>(<issue>3</issue>):<fpage>344</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1007/BF00197271</pub-id><pub-id pub-id-type="pmid">1733836</pub-id></mixed-citation></ref><ref id="R46"><label>46</label><mixed-citation publication-type="journal"><string-name><surname>Rehm</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kehoe</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Gmel</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Stinson</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Grant</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Gmel</surname>
<given-names>G</given-names></string-name>. <article-title>Statistical modeling of volume of alcohol exposure for epidemiological studies of population health: the US example.</article-title>
<source>Popul Health Metr</source>. <year>2010</year>;<volume>8</volume>(<issue>1</issue>):<fpage>3</fpage>. <pub-id pub-id-type="doi">10.1186/1478-7954-8-3</pub-id><pub-id pub-id-type="pmid">20202213</pub-id></mixed-citation></ref><ref id="R47"><label>47</label><mixed-citation publication-type="journal"><string-name><surname>Rey</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Boniol</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Jougla</surname>
<given-names>E</given-names></string-name>. <article-title>Estimating the number of alcohol-attributable deaths: methodological issues and illustration with French data for 2006.</article-title>
<source>Addiction</source>. <year>2010</year>
<month>6</month>;<volume>105</volume>(<issue>6</issue>):<fpage>1018</fpage>&#x02013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1111/j.1360-0443.2010.02910.x</pub-id><pub-id pub-id-type="pmid">20331552</pub-id></mixed-citation></ref><ref id="R48"><label>48</label><mixed-citation publication-type="journal"><string-name><surname>Rehm</surname>
<given-names>J</given-names></string-name>. <article-title>Commentary on Rey et al. (2010): how to improve estimates on alcohol-attributable burden?</article-title>
<source>Addiction</source>. <year>2010</year>
<month>6</month>;<volume>105</volume>(<issue>6</issue>):<fpage>1030</fpage>&#x02013;<lpage>1</lpage>. <pub-id pub-id-type="doi">10.1111/j.1360-0443.2010.02939.x</pub-id><pub-id pub-id-type="pmid">20659062</pub-id></mixed-citation></ref><ref id="R49"><label>49</label><mixed-citation publication-type="journal"><string-name><surname>Shield</surname>
<given-names>KD</given-names></string-name>, <string-name><surname>Kehoe</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Taylor</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Patra</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Rehm</surname>
<given-names>J</given-names></string-name>. <article-title>Alcohol-attributable burden of disease and injury in Canada, 2004.</article-title>
<source>Int J Public Health</source>. <year>2012</year>
<month>4</month>;<volume>57</volume>(<issue>2</issue>):<fpage>391</fpage>&#x02013;<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1007/s00038-011-0247-7</pub-id><pub-id pub-id-type="pmid">21465246</pub-id></mixed-citation></ref><ref id="R50"><label>50</label><mixed-citation publication-type="journal"><string-name><surname>Gmel</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Shield</surname>
<given-names>KD</given-names></string-name>, <string-name><surname>Kehoe-Chan</surname>
<given-names>TAK</given-names></string-name>, <string-name><surname>Rehm</surname>
<given-names>J</given-names></string-name>. <article-title>The effects of capping the alcohol consumption distribution and relative risk functions on the estimated number of deaths attributable to alcohol consumption in the European Union in 2004.</article-title>
<source>BMC Med Res Methodol</source>. <year>2013</year>;<volume>13</volume>(<issue>1</issue>):<fpage>24</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2288-13-24</pub-id><pub-id pub-id-type="pmid">23419127</pub-id></mixed-citation></ref><ref id="R51"><label>51</label><mixed-citation publication-type="book"><string-name><surname>Ezzati</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lopez</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Rodgers</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Murray</surname>
<given-names>CJL</given-names></string-name>. <source>Comparative quantification of health risks. Global and regional burden of disease attributable to selected major risk factors.</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2004</year>.</mixed-citation></ref></ref-list></back></article>